UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________________________________________

FORM 10-Q

____________________________________________________________

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED ~~DECEMBER 28, 2019~~SEPTEMBER 26, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE PERIOD FROM TO .

Commission File Number 0-11559

____________________________________________________________

KEY TRONIC ~~CORPORATION~~CORPORATION

(Exact name of registrant as specified in its charter)

____________________________________________________________



Washington			91-0849125
(State of Incorporation)			(I.R.S. Employer Identification No.)

N. 4424 Sullivan Road

Spokane Valley,, Washington99216

(~~509~~) (509) 928-8000

____________________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements during the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated Filer

☐

Accelerated Filer

☐

Non-accelerated Filer

☒

Smaller reporting company

☒

~~Large accelerated filer~~

☐

~~Accelerated filer~~

☒

~~Non-accelerated filer~~

☐

~~Smaller reporting company~~

☒

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, no par value	KTCC	NASDAQ Global Market

As of ~~February 4,~~November 3, 2020, 10,759,680 shares of common stock, no par value (the only class of common stock), were outstanding.

KEY TRONIC CORPORATION

Index


					Page No.

PART I.			FINANCIAL INFORMATION:

				~~Page No.~~

~~PART I.~~Item 1.	~~FINANCIAL INFORMATION:~~

~~Item 1.~~	Financial Statements (Unaudited):	3

			Condensed Consolidated Balance Sheets		3

			Condensed Consolidated Statements of Income		4

			Condensed Consolidated Statements of Comprehensive Income		5

			Condensed Consolidated Statements of Cash Flows		6

			Condensed Consolidated Statements of Shareholders’ Equity		7

			Notes to Condensed Consolidated Financial Statements		~~8-20~~8-17

Item 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations		~~21-33~~18-28

Item 3.			Quantitative and Qualitative Disclosures about Market Risk		3429

Item 4.			Controls and Procedures		3429

PART II.			OTHER INFORMATION:

Item 1.			Legal Proceedings		3530

Item 1A.			Risk Factors		3530

Item 2.			Unregistered Sales of Equity Securities and Use of Proceeds*

Item 3.			Defaults upon Senior Securities*

Item 4.			Mine Safety Disclosures*

Item 5.			Other Information*

Item 6.			Exhibits		3530

Signatures					3631

* Items are not applicable

“We,” “us,” “our,” “Company,” ~~“KeyTronicEMS”~~ and “KeyTronic,” unless the context otherwise requires, means Key Tronic Corporation and its subsidiaries.

PART I: FINANCIAL INFORMATION

Item 1: Financial Statements

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands; except share data)


	December 28, 2019		June 29, 2019			September 26, 2020		June 27, 2020
ASSETS					ASSETS
Current assets:					Current assets:
Cash and cash equivalents	$	499	$	601	Cash and cash equivalents	$	1,471	$	553
Trade receivables, net of allowance for doubtful accounts of $58 and $58	70,225		58,429
Trade receivables, net of allowance for doubtful accounts of $609 and $609					Trade receivables, net of allowance for doubtful accounts of $609 and $609	91,563		86,123
Contract assets	17,071		22,161		Contract assets	24,458		23,753
Inventories, net	110,144		100,431		Inventories, net	119,791		115,020
Other	20,254		16,477		Other	18,782		17,315
Total current assets	218,193		198,099		Total current assets	256,065		242,764
Property, plant and equipment, net	30,825		29,413		Property, plant and equipment, net	33,316		31,764
Operating lease right-of-use assets, net	14,876		—		Operating lease right-of-use assets, net	16,370		17,568
Other assets:					Other assets:
Deferred income tax asset	8,207		7,840		Deferred income tax asset	9,632		10,178
Other intangible assets, net	—		657
Other	1,869		2,301		Other	2,429		2,587
Total other assets	10,076		10,798		Total other assets	12,061		12,765
Total assets	$	273,970	$	238,310	Total assets	$	317,812	$	304,861
LIABILITIES AND SHAREHOLDERS’ EQUITY					LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:					Current liabilities:
Accounts payable	$	80,448	$	73,571	Accounts payable	$	79,146	$	80,204
Accrued compensation and vacation	6,954		6,759		Accrued compensation and vacation	7,641		10,428
Current portion of debt, net	7,508		5,841		Current portion of debt, net	906		7,508
Other	13,350		7,233		Other	13,957		14,079
Total current liabilities	108,260		93,404		Total current liabilities	101,650		112,219
Long-term liabilities:					Long-term liabilities:
Term loans	7,087		7,091		Term loans	4,021		3,258
Revolving loan	32,018		23,356		Revolving loan	80,414		60,094
Operating lease liabilities	9,780		—		Operating lease liabilities	11,502		12,624
Deferred income tax liability					Deferred income tax liability	232		234
Other long-term obligations	18		—		Other long-term obligations	1,386		875
Total long-term liabilities	48,903		30,447		Total long-term liabilities	97,555		77,085
Total liabilities	157,163		123,851		Total liabilities	199,205		189,304
Commitments and contingencies (Note 9)					Commitments and contingencies (Note 9)
Shareholders’ equity:					Shareholders’ equity:
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,760 and 10,760 shares, respectively	46,821		46,680		Common stock, no par value—shares authorized 25,000; issued and outstanding 10,760 and 10,760 shares, respectively	47,009		46,946
Retained earnings	67,729		65,353		Retained earnings	71,830		70,111
Accumulated other comprehensive gain	2,257		2,426
Accumulated other comprehensive income (loss)					Accumulated other comprehensive income (loss)	(232)		(1,500)
Total shareholders’ equity	116,807		114,459		Total shareholders’ equity	118,607		115,557
Total liabilities and shareholders’ equity	$	273,970	$	238,310	Total liabilities and shareholders’ equity	$	317,812	$	304,861

See accompanying notes to consolidated financial statements.

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited, in thousands, except share and per share amounts)


	Three Months Ended				Six Months Ended					Three Months Ended
	December 28, 2019		December 29, 2018		December 28, 2019		December 29, 2018			September 26, 2020		September 28, 2019
Net sales	$	116,722	$	123,037	$	222,007	$	250,509	Net sales	$	123,207	$	105,285
Cost of sales	108,600		113,157		204,612		231,096		Cost of sales	113,192		96,012
Gross profit	8,122		9,880		17,395		19,413		Gross profit	10,015		9,273
Research, development and engineering expenses	1,720		1,857		3,380		3,557		Research, development and engineering expenses	2,245		1,660
Selling, general and administrative expenses	4,904		5,399		9,978		10,687		Selling, general and administrative expenses	4,974		5,074
Total operating expenses	6,624		7,256		13,358		14,244		Total operating expenses	7,219		6,734
Operating income	1,498		2,624		4,037		5,169		Operating income	2,796		2,539
Interest expense, net	524		708		1,234		1,385		Interest expense, net	681		710
Income before income taxes	974		1,916		2,803		3,784		Income before income taxes	2,115		1,829
Income tax provision	150		327		427		602		Income tax provision	396		277
Net income	$	824	$	1,589	$	2,376	$	3,182	Net income	$	1,719	$	1,552
Net income per share — Basic	$	0.08	$	0.15	$	0.22	$	0.30	Net income per share — Basic	$	0.16	$	0.14
Weighted average shares outstanding — Basic	10,760		10,760		10,760		10,760		Weighted average shares outstanding — Basic	10,760		10,760
Net income per share — Diluted	$	0.08	$	0.15	$	0.22	$	0.29	Net income per share — Diluted	$	0.16	$	0.14
Weighted average shares outstanding — Diluted	10,877		10,881		10,811		10,986		Weighted average shares outstanding — Diluted	11,040		10,805

See accompanying notes to consolidated financial statements.

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited, in thousands)


	Three Months Ended
	September 26, 2020		September 28, 2019
Comprehensive income:
Net income	$	1,719	$	1,552
Other comprehensive income:
Unrealized gain (loss) on hedging instruments, net of tax	1,268		(947)
Comprehensive income	$	2,987	$	605

Three Months Ended Six Months Ended

December 28, 2019 December 29, 2018 December 28, 2019 December 29, 2018
Comprehensive income:
Net income $ 824
$ 1,589
$ 2,376
$ 3,182
Other comprehensive income:
Unrealized gain (loss) on hedging instruments, net of tax 778
(889 ) (169 ) 2,160
Comprehensive income $ 1,602
$ 700
$ 2,207
$ 5,342

Other comprehensive income for the three months ended ~~December~~September 26, 2020 and September 28, 2019, ~~and~~ ~~December 29, 2018~~, is reflected net of tax expense (benefit) of approximately ~~$0.2~~$1.5 million and ~~$(0.2) million, respectively. Other comprehensive income (loss) for the six months ended December 28, 2019 and December 29, 2018, is reflected net of tax expense of approximately $0.1 million and $0.6~~$(0.3) million, respectively.

See accompanying notes to consolidated financial statements.

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited, in thousands)


	Six Months Ended							Three Months Ended
	December 28, 2019			December 29, 2018				September 26, 2020		September 28, 2019
Operating activities:							Operating activities:
Net income	$	2,376		$	3,182		Net income	$	1,719	$	1,552
Adjustments to reconcile net income to cash used in operating activities:							Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization	3,143			3,767			Depreciation and amortization	1,752		1,609
Amortization of deferred loan costs	15			15			Amortization of deferred loan costs	13		8
Provision for obsolete inventory	41			58			Provision for obsolete inventory	178		21
Provision for warranty	89			16			Provision for warranty	19		16

Loss on disposal of assets	206			—			Loss on disposal of assets	0		206
Share-based compensation expense	141			274			Share-based compensation expense	63		74
Deferred income taxes	(318		)	(131		)	Deferred income taxes	(81)		(360)
Changes in operating assets and liabilities:							Changes in operating assets and liabilities:
Trade receivables	(13,514		)	(10,787		)	Trade receivables	(5,449)		(10,140)
Contract assets	5,090			(7,212		)	Contract assets	(705)		399
Cash received from arbitration settlement	—			6,684
Inventories	(9,754		)	7,432			Inventories	(4,949)		(17,327)
Other assets	(3,689		)	(4,963		)	Other assets	292		(829)
Accounts payable	6,877			(3,104		)	Accounts payable	(1,059)		13,643
Accrued compensation and vacation	195			(350		)	Accrued compensation and vacation	(2,787)		600
Other liabilities	664			23			Other liabilities	1,555		215
Cash used in operating activities	(8,438		)	(5,096		)	Cash used in operating activities	(9,439)		(10,313)
Investing activities:							Investing activities:
Purchase of property and equipment	(5,360		)	(3,586		)	Purchase of property and equipment	(3,186)		(3,046)
Proceeds from sale of fixed assets	696			17			Proceeds from sale of fixed assets	0		696
Cash receipts from deferred purchase price of factored receivables	2,695			3,302			Cash receipts from deferred purchase price of factored receivables	0		1,079
Cash used in investing activities	(1,969		)	(267		)	Cash used in investing activities	(3,186)		(1,271)
Financing activities:							Financing activities:
Payment of financing costs	(5		)	(8		)	Payment of financing costs	(307)		(2)
Proceeds from issuance of long term debt	5,000			—			Proceeds from issuance of long term debt	5,000		5,000
Interest rate swap termination fee							Interest rate swap termination fee	(925)		0
Repayments of long term debt	(3,352		)	(2,936		)	Repayments of long term debt	(10,842)		(1,468)
Borrowings under revolving credit agreement	91,216			94,468			Borrowings under revolving credit agreement	45,975		45,799
Repayments of revolving credit agreement	(82,554		)	(86,312		)	Repayments of revolving credit agreement	(25,358)		(37,842)
Cash provided by financing activities	10,305			5,212			Cash provided by financing activities	13,543		11,487
Net decrease in cash and cash equivalents	(102		)	(151		)
Net increase (decrease) in cash and cash equivalents							Net increase (decrease) in cash and cash equivalents	918		(97)
Cash and cash equivalents, beginning of period	601			343			Cash and cash equivalents, beginning of period	553		601
Cash and cash equivalents, end of period	$	499		$	192		Cash and cash equivalents, end of period	$	1,471	$	504
Non-cash investing activities:							Non-cash investing activities:
Beneficial interest in transferred receivables	(1,718		)	(2,117		)	Beneficial interest in transferred receivables	(9)		(1,788)
Supplemental cash flow information:							Supplemental cash flow information:
Interest payments	$	1,235		$	1,332		Interest payments	$	578	$	593
Income tax payments (refunds), net of refunds	$	426		$	(50	)
Income tax payments, net of refunds							Income tax payments, net of refunds	$	351	$	213

See accompanying notes to consolidated financial statements.

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(Unaudited, in thousands; except share data)


	Three Months Ended					Six Months Ended							Three Months Ended
	December 28, 2019		December 29, 2018			December 28, 2019			December 29, 2018				September 26, 2020		September 28, 2019
Total shareholders’ equity, beginning balances	$	115,139	$	123,421		$	114,459		$	118,081		Total shareholders’ equity, beginning balances	$	115,557	$	114,459

Common stock (shares):												Common stock (shares):
Beginning balances	$	10,760	$	10,760		$	10,760		$	10,760		Beginning balances	$	10,760	$	10,760
Exercise of stock appreciation rights	—		—			—			—			Exercise of stock appreciation rights	0		0
Ending balances	10,760		10,760			10,760			10,760			Ending balances	10,760		10,760

Common stock:												Common stock:
Beginning balances	$	46,754	$	46,412		$	46,680		$	46,244		Beginning balances	$	46,946	$	46,680
Share-based compensation	67		106			141			274			Share-based compensation	63		74
Ending balances	46,821		46,518			46,821			46,518			Ending balances	47,009		46,754

Retained Earnings:												Retained Earnings:
Beginning balances	$	66,905	$	74,928		$	65,353		$	72,806		Beginning balances	$	70,111	$	65,353
Net income	824		1,589			2,376			3,182			Net income	1,719		1,552
ASC 606 opening balance sheet adjustment	—		—			—			529
Ending balances	67,729		76,517			67,729			76,517			Ending balances	71,830		66,905

Accumulated other comprehensive income:												Accumulated other comprehensive income:
Beginning balances	$	1,479	$	2,080		$	2,426		$	(969	)	Beginning balances	$	(1,500)	$	2,426
Unrealized gain (loss) on hedging instruments, net	778		(889		)	(169		)	2,160			Unrealized gain (loss) on hedging instruments, net	1,268		(947)
Ending balances	2,257		1,191			2,257			1,191			Ending balances	(232)		1,479
Total shareholder’s equity, ending balances	$	116,807	$	124,226		$	116,807		$	124,226
Total shareholders’ equity, ending balances												Total shareholders’ equity, ending balances	$	118,607	$	115,138

See accompanying notes to consolidated financial statements.

KEY TRONIC CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


1.	~~Basis of Presentation~~

1.Basis of Presentation

The consolidated financial statements included herein have been prepared by Key Tronic Corporation and subsidiaries (the Company) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in our annual consolidated financial statements have been condensed or omitted. The year-end condensed consolidated balance sheet information was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June ~~29, 2019~~.27, 2020.

The Company’s reporting period is a 52/53 week fiscal year ending on the Saturday closest to June 30. The three month period ended September 26, 2020 and ~~six month periods ended December~~September 28, 2019, ~~and December 29, 2018,~~ were 13 ~~and 26~~ week ~~periods, respectively.~~periods. Fiscal year ~~2020~~2021 will end on ~~June 27,2020~~,July 3, 2021, which is a 5253 week year. Fiscal year ~~2019~~2020 which ended on June ~~29, 2019~~,27, 2020, was ~~also~~ a 52 week year.

Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

Due to the COVID-19 pandemic, the Company has seen extreme shifts in demand from its customer base. The possibility of future temporary closures, as well as adverse fluctuations in customer demand, freight and expedite costs, precautionary safety expenses and labor shortages, collectability of accounts, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results. Additionally, continued adverse macroeconomic conditions and significant currency exchange fluctuations can also materially impact operating results.

2.Significant Accounting Policies


2.	~~Significant Accounting Policies~~

Earnings Per Common Share

Basic earnings per common share (EPS) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income (loss) by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.

Derivative Instruments and Hedging Activities

The Company has entered into foreign currency forward contracts ~~foreign currency swaps and an interest rate swap which~~that are accounted for as cash flow hedges in accordance with ASC 815, “Derivatives and Hedging”. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.

The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico ~~facilities and interest rate risk associated with certain borrowings under the Company’s term loan arrangement.~~facilities. The foreign currency forward contracts ~~foreign currency swaps and interest rate swap~~ have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.

The Company’s foreign currency forward contracts ~~and interest rate swap~~ potentially expose the Company to credit risk to the extent the counterparty may be unable to meet the terms of the agreement. The Company minimizes such risk by utilizing a counterparty with a strong credit rating. The Company’s counterparty to the foreign currency forward contracts ~~foreign currency swaps and interest rate swap~~ is a major banking institution. This institution does not require collateral for the contracts, and the Company believes that the risk of the counterparty failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.

Income Taxes

We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.

We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. The tax years 1998 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 6 for further discussions.

~~Impairment of Goodwill and Other Intangible Assets~~

~~The Company records intangible assets that are acquired individually or with a group of other assets in the financial statements at acquisition. In accordance with ASC 350,~~ ~~Goodwill and Other Intangible Assets~~, goodwill and intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company’s acquired intangible assets are subject to amortization over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. Refer to footnote 12 for recognition of intangible asset in accordance with ASC 842.

Recently Issued Accounting Standards

In ~~February 2016,~~March of 2020, the FASB issued ~~Accounting Standards Update~~ASU 2020-03, Codification Improvements to Financial Instruments, which clarifies specific issues raised by stakeholders. Specifically, the ASU clarifies the following: 1) that all entities are required to provide the fair value option disclosures in ASC ~~2016-02, Leases which supersedes~~825, Financial Instruments 2) clarifies that the portfolio exception in ASC ~~840 Leases~~820, Fair Value Measurement, applies to nonfinancial items accounted for as derivatives under ASC 815, Derivatives and ~~creates~~Hedging; 3) clarifies that for purposes of measuring expected credit losses on a ~~new topic,~~net investment in a lease in accordance with ASC 326, Financial Instruments - Credit Losses, the lease term determined in accordance with ASC 842, ~~Leases. This update requires lessees to~~Leases, should be used as the contractual term; 4) clarifies that when an entity regains control of financial assets sold, it should recognize ~~a lease asset~~an allowance for credit losses in accordance with ASC 326; and ~~a lease liability~~5) aligns the disclosure requirements for ~~all leases, including operating leases,~~debt securities in ASC 320, Investments - Debt Securities, with ~~a term greater than 12 months~~the corresponding requirements for depository and lending institutions in ASC 942, Financial Services - Depository and Lending. The amendments in the ASU have various effective dates and transition requirements which are dependent on timing of adoption of ASU 2016-13. The Company is currently assessing the effects on its ~~balance sheet. The update also expands~~consolidated financial statements, and it intends to adopt the ~~required quantitative and qualitative disclosures surrounding leases.~~ guidance as they become effective.

In ~~July 2018,~~December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting ~~Standards Update 2018-10, Codification Improvements~~for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to ~~Topic 842, Leases. The update~~reduce the complexity of accounting for income taxes. ASU 2019-12 is intended to clarify certain aspects of the new lease standard, Topic 842. The amendments affect narrow aspects of the guidance issued in update 2016-02 discussed above. The amendments address residual value guarantees, the rate implicit in the lease, certain lessee and lessor reassessments, variable lease payments that depend on an index or rate, investment tax credits, lease term and purchase option, transition guidance and certain adjustments, impairment of the net investment in the lease, residual assets that are not guaranteed, as well as other areas of improvement and clarification. The amendments have the same effective ~~date and transition requirements as the new lease standard.~~

~~The Company adopted ASC 842 on June 30, 2019 using the modified retrospective method~~ for ~~leases existing at, or entered into after, June 30, 2019. As a result,~~ the Company ~~was~~the first quarter of fiscal year 2022. We are currently evaluating the effects and do not ~~required to adjust its comparative period financial information for effects of the~~believe this standard or make the new required lease disclosures for periods before our adoption date. Management elected the package of practical expedients which, among other things, allows the Company to carry forward historical lease classification in place prior to June 30, 2019. ASC 842 also provides practical expedients for an entity’s accounting after transition. Management has elected the short-term lease recognition exemption for all leases that qualify, as well as the practical expedient to not separate lease and non-lease components. Both of these expedients were elected for all classes of underlying leased assets. As the Company cannot determine the interest rate implicit in the lease for its leases, the Company uses its estimate of the incremental borrowing rate as of the commencement date in determining the present value of lease payments. The Company’s estimated incremental borrowing rate is the rate of interest it wouldwill have to pay on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment. The lease term for all of the Company’s leases includes the noncancellable period of the lease plus any additional periods covered by either an option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise.

~~The adoption of ASC 842 had~~ a material impact ~~to the Company’s~~on our consolidated ~~balance sheet, but did not materially impact the consolidated statement~~financial position, results of ~~income~~operations, or ~~consolidated statement of~~ cash flows. ~~The most significant changes to the consolidated balance sheet relate to the recognition of new right-of-use (ROU) assets and lease liabilities for operating leases.~~

As a result of adopting ASC 842 as of June 30, 2019, the Company recognized an ROU asset of $17.2 million, a corresponding lease liability of $16.2 million, a reduction in prepaid rent of $0.4 million, a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing ~~and expects~~ the ~~new guidance to have an immaterial~~ impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024.


3.	~~Inventories~~

3.Inventories

The components of inventories consist of the following (in thousands):


	September 26, 2020		June 27, 2020
Finished goods	$	15,632	$	15,269
Work-in-process	21,418		17,390
Raw materials and supplies	82,741		82,361
	$	119,791	$	115,020

December 28, 2019 June 29, 2019
Finished goods $ 14,320
$ 11,969
Work-in-process 20,638
11,705
Raw materials and supplies 75,186
76,757
$ 110,144
$ 100,431

Total inventory as of ~~December 28, 2019~~September 26, 2020 is net of ~~$11.9~~$14.5 million of reserves, customer payments, and customer deposits compared to ~~$10.0~~$17.3 million in reserves, customer payments, and customer deposits as of June ~~29, 2019.~~27, 2020.

4.Long-Term Debt


4.	~~Long-Term Debt~~

On ~~September 10, 2019,~~August 14, 2020, the Company entered into a ~~Fifth amendment to~~loan agreement with Bank of America. The Loan Agreement replaces the Company’s prior amended and restated credit agreement, as amended, with Wells Fargo Bank. The Loan Agreement provides for a five-year asset-based senior secured revolving credit facility of up to ~~increase~~$93 million, maturing on August 14, 2025. As of September 26, 2020, the outstanding balance on the term loan in the amount of $5.0 million and to extend the maturity date to September 30, 2022 on the original term loan in the amount of $35.0 million that was used to acquire all of the outstanding shares of CDR Manufacturing, Inc. (dba Ayrshire Electronics). The term loan requires quarterly payments of $1.67 million commencing December 31, 2019 through September 30, 2021, and quarterly payments of $0.4 million commencing December 31, 2021 through September 30, 2022, with a final payment of the remaining outstanding balance on September 30, 2022. The Company had an outstanding balance under the asset-based revolving credit facility of ~~$13.3~~$80.7 million and ~~$11.3~~$12.3 million ~~under the term loan as of December 28, 2019 and June 29, 2019, respectively.~~available for future borrowings.

On November 20, 2019, the Company entered into a Sixth amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $55.0 million as evidenced by the Second Replacement Revolving Note. The agreement specifies that the proceeds of the revolving line of credit be used primarily for working capital and general corporate purposes. The line of credit is secured by substantially all of the assets of the Company. On September 30, 2018, the Company entered into a Fourth amendment to the amended and restated credit agreement to extend the maturity date to November 1, 2023, at which time all outstanding balances are payable. As of ~~December 28, 2019,~~June 27, 2020, the Company had an outstanding balance under the credit facility with Wells Fargo Bank of ~~$32.0~~$60.1 million, $0.4 million in outstanding letters of credit and ~~$22.6~~$4.5 million available for future borrowings. ~~As of June 29, 2019, the~~The Company had an outstanding balance of $10.0 million under the ~~credit facility~~term loan with Wells Fargo Bank as of ~~$23.4 million, $0.4 million in outstanding letters of credit and $21.3 million available for future borrowings.~~June 27, 2020.

On ~~December 28, 2016,~~August 14, 2020, the Company also entered into ana $5.0 million equipment ~~term loan agreement in~~financing facility relating to the ~~amount of $3.9 million in order to further invest in production equipment. The~~Company’s existing U.S. manufacturing equipment ~~term loan is collateralized by production equipment.~~that bears interest at 4.85% and matures on August 14, 2025. Under this loan agreement, equal ~~quarterly~~monthly payments of approximately ~~$0.2 million~~$94,000 commenced on ~~March 31, 2017~~September 14, 2020 and will continue through the maturity of the equipment ~~term loan~~financing facility on ~~June 30, 2021. Amortization of the debt issuance costs is reported as interest expense on the consolidated income statement.~~August 14, 2025. As of ~~December 28, 2019,~~September 26, 2020, the Company had an outstanding balance of ~~$1.3~~$4.9 million. As of June ~~29, 2019,~~27, 2020, the Company had an outstanding balance of ~~$1.7 million.~~

~~The Fifth amendment to the amended and restated credit agreement noted above to increase the outstanding balance on the term loan in the amount of $5.0~~$0.9 million ~~fixes borrowings~~ under the revolving line of credit, term loan and equipment term loan to bear interest at LIBOR plus 2.0%, as opposed to previous borrowings at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. The base rate is the higher of the Wells Fargo Bank ~~prime rate, daily one month London Interbank Offered Rate (LIBOR) plus~~ ~~1.5%, or the Federal Funds rate plus~~ ~~1.5%. The fixed rate is LIBOR plus 1.75%, LIBOR plus~~ ~~2.00%, or LIBOR plus 2.25% depending on the level of the Company’s trailing four quarters Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA).~~ equipment term loan agreement.

The interest rates on outstanding debt as of ~~December 28, 2019~~September 26, 2020 range from ~~3.71%~~3.00% - ~~3.80%~~4.85% compared to ~~4.40%~~2.17% - ~~5.50%~~2.18% as of June ~~29, 2019.~~27, 2020.

Generally, the interest rate applicable to loans under the loan agreement will be, at the Company’s option: (i)(A) the base rate which is the highest of (1) the prime rate for the applicable day (as such rate is determined from time to time by the Bank), (2) the federal funds rate for the applicable day plus 0.50%, and (3) LIBOR for a 30-day interest period as of the applicable day plus 1.00% (provided that in no event shall the base rate be less than zero), plus the applicable interest margin for base rate loans; and (B) LIBOR rate for an applicable interest period (provided that in no event shall the LIBOR rate be less than 0.50%), plus the applicable interest margin for LIBOR rate loans. Depending on average daily excess borrowing availability over applicable periods under the Credit Facility, applicable interest margins on: (x) base rate loans will be 1.25-1.75%; and (y) LIBOR rate loans will be 2.25-2.75%, resetting on a quarterly basis beginning in early 2021. If there is an event of default under the loan agreement, all loans and other obligations will bear interest at a rate of an additional 2.00% on the otherwise applicable interest rates. In addition to interest charges, the Company is required to pay a fee of 0.25% per annum on the unused portion of the Credit Facility, monthly in arrears.

Under the new loan agreement with Bank of America, the asset-based revolving credit facility bears interest at LIBOR plus 2.5%, as elected by the Company.

Debt maturities as of ~~December 28, 2019~~September 26, 2020 for the next five years and thereafter are as follows (in thousands):


Fiscal Years Ending	Amount			Fiscal Years Ending	Amount
2020 ⁽¹⁾	$	3,769
2021	7,537
2021 (1)				2021 (1)	$	678
2022	2,917			2022	943
2023	417			2023	989
2024	32,018			2024	1,039
2025				2025	1,090
Thereafter				Thereafter	80,899
Total debt	$	46,658		Total debt	$	85,638
Unamortized debt issuance costs	(45		)	Unamortized debt issuance costs	(297)
Long-term debt, net of debt issuance costs	$	46,613		Long-term debt, net of debt issuance costs	$	85,341

(1)Represents scheduled payments for the remaining ~~six-month~~nine-month period ending ~~June 27, 2020.~~July 3, 2021.

The Company must comply with certain financial covenants, including a ~~cash flow leverage ratio, an asset~~fixed charge coverage ratio and a ~~fixed charge coverage~~cash flow leverage ratio. The credit agreement requires the Company to ~~maintain a minimum profit threshold, limits~~grant certain inspection rights to the ~~maximum capital lease expenditures and restricts~~Bank, limit or restrict the Company’s cash management; limit or restrict the ability of the Company ~~from declaring~~to incur additional liens, make acquisitions or ~~paying~~investments, incur additional indebtedness, engage in mergers, consolidations, liquidations, dissolutions, or dispositions, pay dividends or other restricted payments, prepay certain indebtedness, engage in ~~cash or stock without prior bank approval.~~transactions with affiliates, and use proceeds. The Company was in compliance with all financial covenants as of ~~December 28, 2019.~~September 26, 2020.

5.Trade Accounts Receivable Purchase Programs


5.	~~Trade Accounts Receivable Purchase Programs~~

Sale Programs

The Company ~~utilizes~~has utilized an Account Purchase Agreement with Wells Fargo Bank, N.A. (“WFB”) which ~~allows~~allowed the Company to sell and assign to WFB and WFB ~~may~~to purchase from the Company the accounts receivable of certain Company customers in a maximum aggregate amount outstanding of $25.0 million. ~~This agreement may be cancelled at any time by either party.~~ As of September 26, 2020, the Company had no factored receivables with WFB.

The Company ~~also has an Account Purchase Agreement with Orbian Financial Services (“Orbian”). This agreement allows~~did not sell any accounts receivables during the ~~Company to sell accounts receivable of certain customers to Orbian and the agreement may be cancelled at any time by either party.~~

three months ended September 26, 2020. Total accounts receivables sold during the ~~six~~three months ended ~~December~~September 28, 2019 ~~and December 29, 2018~~ was approximately ~~$35.0 million and $41.1 million, respectively.~~$17.8 million. Accounts receivables sold and not yet collected ~~were $1.7 million and $1.7 million~~was $9,000 as of ~~December 28, 2019 and~~ June ~~29, 2019, respectively.~~27, 2020. The receivables that were sold were removed from the condensed consolidated balance sheets and the cash received is reflected as cash provided by operating activities in the condensed consolidated statements of cash flows. Cash receipts related to the deferred purchase price from receivables factored by the Company is reflected as cash provided by investing activities.


6.	~~Income Taxes~~

~~On December 22, 2017,~~6.Income Taxes

The Company expects to repatriate a portion of its foreign earnings based on increased net sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company currently expects to repatriate approximately $8.0 million of foreign earnings in the ~~Tax Cuts~~future. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and Jobs Act (“Tax Act”) was signed into law. The Tax Act reduced Federal corporate tax rates effective January 1, 2018 and changed certain other provisions, many of which were not effective until fiscal year 2019.improvements in foreign locations.

As a result of the change of the U.S. tax system under the Tax Act from a global to a territorial model, a deemed one-time repatriation of all accumulated earnings and profits (AE&P) in Mexico and China occurred on December 31, 2017 (the “Transition Tax”).

On December 22, 2017, the staff of the SEC issued Staff Accounting Bulletin No. 118 (“SAB No. 118”). SAB No. 118 provides guidance on accounting for the tax effects of the 2017 Tax Act and allows registrants to record provisional amounts for a period of up to one year from the date of enactment of the 2017 Tax Act. In fiscal year 2019 we finalized the effects of the Tax Act, resulting in a net Transition Tax amount of $0.8 million, a decrease of $0.4 million compared to the amount provisioned in fiscal year 2018.

~~In future years, because of the Transition Tax on AE&P described above, repatriations~~Repatriations of cash will generally be tax-free in the U.S. However, withholding taxes in China may still apply to any such future repatriations. Management has not changed its indefinite investment assertions with regard to the portion of ~~AE&P~~accumulated earnings and profits in China that may be repatriated in the future. Accordingly, management estimates that future repatriations of cash from China may result in approximately $0.8 million of withholding tax. There would be no offsetting foreign tax credits in the U.S. and as such, this potential liability is a direct cost associated with actual repatriations. Withholding taxes will not apply to future repatriations from Mexico or Vietnam.

~~The Company~~ has available approximately ~~$9.4~~$8.7 million of gross federal research and development tax credits as of ~~December 28, 2019.~~September 26, 2020. ASC 740 requires the Company to recognize in its financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. Accordingly, as of ~~December 28, 2019,~~September 26, 2020, the Company has recorded ~~$4.1~~$2.9 million of unrecognized tax benefits associated with these federal tax credits, resulting in a net deferred tax benefit of approximately ~~$5.3~~$5.8 million.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss (NOL) carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company does not expect that the NOL carryback provision of the CARES Act will result in a material cash benefit. In addition, the CARES Act contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020. The modifications to Section 163(j) increase the allowable business interest deduction from 30% of adjusted taxable income to 50% of adjusted taxable income. This modification (in connection with related modifications included in final regulations issued in the first quarter of fiscal year 2021) would increase the allowable interest expense deduction of the Company and result in less taxable income for fiscal years 2020 and 2021, but is not expected to have a material impact on the provision for income taxes. Also, under the CARES Act, AMT credits not previously refunded for the 2018 tax year are refundable in the 2019 taxable year rather than in years 2019-2021, and taxpayers can elect to claim 100% of the AMT credits in the first taxable year beginning in 2018 by applying for a tentative refund claim on or before December 31, 2020. The Company made this election by applying for a tentative refund claim in the fourth quarter of fiscal year 2020. The Company is continuing to evaluate the impacts of other aspects of the CARES Act, and at this time the Company does not believe they will have a material impact on our consolidated financial position, results of operations, or cash flows.


7.	~~Earnings Per Share~~

7.Earnings Per Share

The following ~~tables present~~table presents a reconciliation of the denominator in the basic and diluted EPS calculation and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.

Three Months Ended
(in thousands, except share and per share information)
December 28, 2019 December 29, 2018
Net income $ 824
$ 1,589
Weighted average shares outstanding—basic 10,760
10,760
Effect of dilutive common stock awards 117
121
Weighted average shares outstanding—diluted 10,877
10,881
Net income per share—basic $ 0.08
$ 0.15
Net income per share—diluted $ 0.08
$ 0.15
Antidilutive SARs not included in diluted earnings per share 725
1,035


	Three Months Ended
	(in thousands, except share and per share information)
	September 26, 2020		September 28, 2019
Net income	$	1,719	$	1,552
Weighted average shares outstanding—basic	10,760		10,760
Effect of dilutive common stock awards	280		45
Weighted average shares outstanding—diluted	11,040		10,805
Net income per share—basic	$	0.16	$	0.14
Net income per share—diluted	$	0.16	$	0.14
Antidilutive SARs not included in diluted earnings per share	329		940

Six Months Ended
(in thousands, except share and per share information)
December 28, 2019 December 29, 2018
Net income $ 2,376
$ 3,182
Weighted average shares outstanding—basic 10,760
10,760
Effect of dilutive common stock awards 51
226
Weighted average shares outstanding—diluted 10,811
10,986
Net income per share—basic $ 0.22
$ 0.30
Net income per share—diluted $ 0.22
$ 0.29
Antidilutive SARs not included in diluted earnings per share 725
793

8. Share-based Compensation

The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.

In addition to service conditions, SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are evaluated quarterly to determine the likelihood that performance metrics will be achieved during the performance period. These awards are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant.

The grant date fair value for the awards granted below were estimated using the Black Scholes option valuation method:

July 26, 2019 July 27, 2018
SARs Granted 170,000
161,250
Strike Price $ 4.93
$ 8.17
Fair Value $ 1.23
$ 2.27


	July 23, 2020		July 26, 2019
SARs Granted	155,000		175,000
Strike Price	$	6.94	$	4.93
Fair Value	$	2.32	$	1.23

Total share-based compensation expense recognized during the three months ended ~~December~~September 26, 2020 and September 28, 2019 ~~and December 29, 2018~~ was approximately ~~$67,000~~$64,000 and ~~$106,000, respectively. Total share-based compensation expense recognized during the six months ended December 28, 2019 and December 29, 2018 was approximately $141,000 and $274,000,~~$74,000, respectively.

As of ~~December 28, 2019,~~September 26, 2020, total unrecognized compensation expense related to unvested share-based compensation arrangements was approximately ~~$0.3~~$0.5 million. This expense is expected to be recognized over a weighted average period of ~~1.80~~2.33 years. No SARs were exercised during the three ~~or six~~ months ended ~~December~~September 26, 2020 or September 28, ~~2019 or December 29, 2018.~~2019.


9.	~~Commitments and Contingencies~~

9.Commitments and Contingencies

Litigation and Other Matters

The Company is party to certain lawsuits or claims in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the financial position, results of operations or cash flow of the Company.

Warranties

The Company provides warranties on certain product sales. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. If actual return rates and/or repair and replacement costs differ significantly from management’s estimates, adjustments to recognize additional cost of sales may be required in future periods. The Company’s warranty reserve was approximately ~~$11,000~~$13,000 as of ~~December 28, 2019~~September 26, 2020 and ~~$22,000~~$15,000 as of June 27, 2020, respectively.

10.~~June 29, 2019, respectively.~~Derivative Financial Instruments


~~10.~~	~~Derivative Financial Instruments~~

As of ~~December 28, 2019~~,September 26, 2020, the Company had outstanding foreign currency forward contracts with a total notional amount of ~~$25.8 million~~.$30.0 million. The maturity dates for these contracts extend through December ~~2020.~~2021. For the three months ended ~~December 28, 2019,~~September 26, 2020, the Company did not enter into any foreign currency forward contracts and settled ~~$7.2~~$6.7 million of ~~such~~ contracts. During the same period of the previous year, ~~the Company entered into foreign currency forward contracts of $6.3 million and settled $6.7 million of such contracts.~~

~~For the six months ended December 28, 2019,~~ the Company did not enter into any foreign currency forward contracts and settled ~~$13.9~~$6.7 million of ~~such contracts. During the same period of the previous year, the Company entered into foreign currency forward contracts of $6.3 million and settled $12.0 million of such~~ contracts.

As of ~~December 28, 2019,~~September 26, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):

Quarter Ending Notional Contracts in MXN Notional Contracts in USD Estimated Fair Value
March 28, 2020 $ 146,613
$ 6,553
$ 1,177
June 27, 2020 $ 138,213
$ 6,257
$ 929
September 26, 2020 $ 141,173
$ 6,729
$ 516
December 26, 2020 $ 132,773
$ 6,241
$ 488


Quarter Ending	Notional Contracts in MXN		Notional Contracts in USD		Estimated Fair Value
December 26, 2020	$	132,773	$	6,241	$	(333)
April 3, 2021	$	148,253	$	6,682	$	(161)
July 3, 2021	$	144,725	$	6,446	$	(134)
October 2, 2021	$	146,373	$	5,502	$	805
January 1, 2022	$	137,973	$	5,129	$	754

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, related to the borrowings outstanding under the term ~~loan.~~loan with Wells Fargo Bank. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.70% that replaces the one month LIBOR rate component of our contractual interest to be paid to ~~WFB~~Wells Fargo Bank as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $148,400, which will be amortized to interest expense over the original term of the swap.

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, related to the borrowings outstanding under the line of ~~credit.~~credit with Wells Fargo Bank. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.67% that replaces the one month LIBOR rate component of our contractual interest to be paid to ~~WFB~~Wells Fargo Bank as part of our line of credit. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the line of credit, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $776,500, which will be amortized to interest expense over the original term of the swap.

The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of ~~December 28, 2019~~September 26, 2020 and June ~~29, 2019~~27, 2020 (in thousands):


		September 26, 2020		June 27, 2020
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value		Fair Value
Foreign currency forward contracts	Other current assets	$	771	$	0
Foreign currency forward contracts	Other long-term assets	$	788	$	1,097
Foreign currency forward contracts	Other current liabilities	$	(628)	$	(1,960)
Foreign currency forward contracts	Other long-term liabilities	$	0	$	(17)
Interest rate swap	Other current liabilities	$	0	$	(347)
Interest rate swap	Other long-term liabilities	$	0	$	(610)

December 28, 2019 June 29, 2019
Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Fair Value
Foreign currency forward contracts & swaps Other current assets $ 3,110
$ 2,912
Foreign currency forward contracts & swaps Other long-term assets $ —
$ 320
Interest rate swap Other current assets $ 6
$ 2
Interest rate swap Other current liabilities $ (83 ) $ —
Interest rate swap Other long-term liabilities $ (17 ) $ —

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended ~~December~~September 26, 2020 and September 28, 2019, ~~and~~ ~~December 29, 2018, respectively (in thousands):~~

Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance
as of
September 28, 2019
Effective
Portion
Recorded In
AOCI

Effective Portion
Reclassified From
AOCI Into
Income
AOCI Balance
as of
December 28, 2019
Forward contracts & swaps Cost of sales $ 1,479
$ 1,533
$ (683 ) $ 2,329
Interest rate swap Interest expense —
(71 ) (1 ) (72 )
Total $ 1,479
$ 1,462
$ (684 ) $ 2,257

Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance
as of
September 29, 2018
Effective
Portion
Recorded In
AOCI

Effective Portion
Reclassified From
AOCI Into
Income
AOCI Balance
as of
December 29, 2018
Forward contracts & swaps Cost of sales $ 2,061
$ (1,266 ) $ 383
$ 1,178
Interest rate swap Interest expense 19
(1 ) (5 ) 13
Total $ 2,080
$ (1,267 ) $ 378
$ 1,191

~~The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the six months ended December 28, 2019 and December 29, 2018,~~ respectively (in thousands):

Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance
as of
June 29, 2019
Effective
Portion
Recorded In
AOCI

Effective Portion
Reclassified From
AOCI Into
Income
AOCI Balance
as of
December 28, 2019
Forward contracts & swaps Cost of sales $ 2,424
$ 1,492
$ (1,587 ) $ 2,329
Interest rate swap Interest expense 2
(71 ) (3 ) (72 )
Total $ 2,426
$ 1,421
$ (1,590 ) $ 2,257

Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance
as of
June 30, 2018
Effective
Portion
Recorded In
AOCI

Effective Portion
Reclassified From
AOCI Into
Income
AOCI Balance
as of
December 29, 2018
Forward contracts & swaps Cost of sales $ (988 ) $ 1,249
$ 917
$ 1,178
Interest rate swap Interest expense 19
1
(7 ) 13
Total $ (969 ) $ 1,250
$ 910
$ 1,191


Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 27, 2020		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 26, 2020
Forward contracts	Cost of sales	$	(759)	$	1,043	$	359	$	643
Interest rate swap	Interest expense	(741)		(223)		89		(875)
Total		$	(1,500)	$	820	$	448	$	(232)

Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 29, 2019		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 28, 2019
Forward contracts	Cost of sales	$	2,424	$	(41)	$	(904)	$	1,479
Interest rate swap	Interest expense	2		0		(2)		0
Total		$	2,426	$	(41)	$	(906)	$	1,479

As of ~~December 28, 2019~~,September 26, 2020, the net amount of unrealized gain expected to be reclassified into earnings within the next 12 months is approximately ~~$2.3 million~~.$0.1 million. As of ~~December 28, 2019~~,September 26, 2020, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.


11.	~~Fair Value Measurements~~

~~The Company has adopted ASC 820,~~ Fair Value Measurements~~, which defines fair value, establishes~~

The Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso. These contracts are measured on a ~~framework for assets~~recurring basis based on the foreign currency spot rates and ~~liabilities being measured and reported at fair value and expands disclosures about fair value measurements.~~forward rates quoted by banks or foreign currency dealers. There are three levels of fair value hierarchy inputs used to value assets and liabilities which include: Level 1 – inputs are quoted market prices for identical assets or liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – inputs are unobservable inputs for the asset or liability. These contracts are marked to market using level 2 input criteria every quarter with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive gain (loss), as they qualify for hedge accounting.

The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of ~~December 28, 2019~~September 26, 2020 and June ~~29, 2019~~27, 2020 (in thousands):


	September 26, 2020
	Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:

Foreign currency forward contracts	$	0	$	1,559	$	0	$	1,559
Financial Liabilities:

Foreign currency forward contracts	$	0	$	(628)	$	0	$	(628)


	December 28, 2019											June 27, 2020
	Level 1		Level 2			Level 3		Total Fair Value				Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:											Financial Assets:
Interest rate swaps	$	—	$	6		$	—	$	6

Foreign currency forward contracts	$	—	$	3,110		$	—	$	3,110		Foreign currency forward contracts	$	0	$	1,097	$	0	$	1,097
Financial Liabilities:											Financial Liabilities:
Interest rate swap	$	—	$	(100	)	$	—	$	(100	)	Interest rate swap	$	0	$	(957)	$	0	$	(957)
Foreign currency forward contracts											Foreign currency forward contracts	$	0	$	(1,977)	$	0	$	(1,977)

June 29, 2019
Level 1 Level 2 Level 3
Total
Fair Value
Financial Assets:
Interest rate swaps $ —
$ 2
$ —
$ 2
Foreign currency forward contracts & swaps $ —
$ 3,232
$ —
$ 3,232

The Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso and an interest rate swap to mitigate risk associated with certain borrowings under the Company’s debt arrangement. These contracts are measured on a recurring basis based on the foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. These contracts are marked to market using level 2 input criteria every period with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive loss, as they qualify for hedge accounting.

The carrying values of cash and cash equivalents, accounts receivable and current liabilities reflected on the balance sheets at ~~December 28, 2019~~September 26, 2020 and June ~~29, 2019~~,27, 2020, reasonably approximate their fair value. The Company’s long-term debt, which is measured at amortized cost, primarily consists of aan asset-based revolving ~~line of~~ credit ~~a term loan~~facility, lease liability, and an equipment ~~term~~ loan. These borrowings bear interest at LIBOR plus ~~2.0%~~2.5% per the ~~Fifth amendment to the amended and restated credit agreement, as opposed to the previous interest at either a “Base Rate” or a “Fixed Rate,” as elected by the Company.~~loan agreement. Each of these rates is a variable floating rate dependent upon current market conditions and the Company’s current credit risk as discussed in footnote 4.

As a result of the determinable market rates for our asset-based revolving ~~line of~~ credit ~~term loan~~facility and equipment ~~term~~ loan, they are classified within Level 2 of the fair value hierarchy. Further, the carrying value of each of these instruments reasonably approximates their fair value as of ~~December 28, 2019~~September 26, 2020 and June ~~29, 2019.~~27, 2020.


~~12.~~	~~Goodwill and Other Intangible Assets~~

~~The Company recorded intangible assets in connection with the Ayrshire and Sabre acquisitions resulting primarily favorable lease agreements.~~

In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates intangible assets for impairment at the reporting unit level annually, and whenever circumstances occur indicating that intangibles might be impaired.

During the third quarter for fiscal year 2019, the Company assessed other finite-lived intangible assets including the Company’s customer relationships and favorable lease agreements due to an indicator of possible impairment being present. As a result of the analysis performed, the Company determined that the carrying value of the customer relationships intangible asset was not recoverable and recorded an impairment for the entire carrying amount during the third quarter of fiscal year 2019. This resulted in an impairment charge related to other intangible assets of $2.5 million recognized in the third quarter of fiscal year 2019. The Company’s analysis did not indicate that any of its other long-lived assets were impaired.

During the first quarter of fiscal year 2020, the Company adopted the Accounting Standards Update 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. Under ASC 842, any assets or liabilities recognized in accordance with ASC 805 that are related to favorable or unfavorable terms of an operating lease for which an entity is a lessee, the entity should derecognize the asset or liability and commensurately adjust the ROU asset.

As such, the Company derecognized the intangible asset and added the offsetting amount to the ROU asset. Resulting in a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact.

~~The components of acquired intangible assets are as follows (in thousands):~~

December 28, 2019

Amortization Period
in Years

Gross Carrying
Amount

Accumulated
Amortization

Impairment
Recognized
Derecognition Favorable Lease per ASC 842
Net Carrying
Amount
Intangible assets:
Favorable Lease Agreements 4 - 7 2,941
(2,284 ) —
(657 ) —
Total $ 2,941
$ (2,284 ) $ —
$ (657 ) $ —

June 29, 2019

Amortization Period
in Years

Gross Carrying
Amount

Accumulated
Amortization
Impairment
Recognized
Net Carrying
Amount
Intangible assets:
Non-Compete Agreements 3 - 5 $ 568
$ (568 ) $ —
$ —
Customer Relationships 10 4,803
(2,311 ) (2,492 ) —
Favorable Lease Agreements 4 - 7 2,941
(2,284 ) —
657
Total $ 8,312
$ (5,163 ) $ (2,492 ) $ 657

12.Revenue

Amortization expense was approximately $0 and $196,000 for the three months ended December 28, 2019 and December 29, 2018, respectively. Amortization expense was approximately $0 and $426,000 for the six months ended December 28, 2019 and December 29, 2018, respectively.


~~13.~~	~~Revenue~~

Revenue Recognition

The Company specializes in services ranging from product manufacturing to engineering and tooling services. The first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates.

The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed.

The Company’s typical payment terms are 30 to 4590 days and its sales arrangements do not contain any significant financing component for its customers.

The Company generally provides a warranty for workmanship on its manufacturing contracts. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s warranties.

The Company elected to not disclose information about remaining performance obligations as they are part of contracts that that have expected durations of one year or less.

During the first quarter of fiscal ~~2020,~~year 2021, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods.

Contract Balances

A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional. The following table summarizes the activity in the Company’s contract assets during the ~~six~~three months ended ~~December 28, 2019~~September 26, 2020 (in thousands):

Contract Assets
Beginning balance, June 29, 2019 $ 22,161
Revenue recognized 219,144
Amounts collected or invoiced (224,234 )
Ending balance, September 28, 2019 $ 17,071


	Contract Assets
Beginning balance, June 27, 2020	$	23,753
Revenue recognized	120,783
Amounts collected or invoiced	(120,078)
Ending balance, September 26, 2020	$	24,458

Disaggregation of Revenue

The following table presents the Company’s revenue disaggregated for the three ~~and six~~ months ended ~~December~~September 26, 2020 and September 28, 2019 (in thousands):


	EMS Revenue
Recognition	Three Months Ended
	September 26, 2020		September 28, 2019
Over-Time	$	120,836	$	104,026
Point-in-Time	2,371		1,259
Total	$	123,207	$	105,285

EMS Revenue
Recognition Three Months Ended Six Months Ended
December 28, 2019 December 29, 2018 December 28, 2019 December 29, 2018
Over-Time $ 115,118
$ 122,137
$ 219,144
$ 248,518
Point-in-Time 1,604
900
2,863
1,991
Total $ 116,722
$ 123,037
$ 222,007
$ 250,509

13.Leases


~~14.~~	~~Leases~~

The Company has several commitments under operating leases for warehouses, manufacturing facilities, office buildings, and equipment with initial terms that expire at various dates during the next 1 year to 1211 years.

The components of lease cost for the three ~~and six~~ months ended ~~December 28, 2019~~September 26, 2020 were (in thousands):

Lease cost

Classification

Three Months Ended

Operating lease cost

Cost of sales

1,164

Operating lease cost

Selling, general and administrative expenses

338

Total lease cost

1,502

Lease cost Classification Three-Month Period Ended Six-Month Period Ended
Operating lease cost Cost of sales $ 1,161
$ 2,319
Operating lease cost Selling, general and administrative expenses 331
598
Total lease cost $ 1,492
$ 2,917

Amounts reported in the Consolidated Balance Sheet as of ~~December 28, 2019~~September 26, 2020 were (in thousands, except weighted average lease term and discount rate):

December 28, 2019
Operating Leases:
Operating lease right of use assets $ 14,876
Operating lease liabilities ⁽¹⁾
14,329

Weighted-average remaining lease term (in years)
Operating leases 6.29

Weighted-average discount rate
Operating leases 4.1 %


	September 26, 2020
Operating Leases:
Operating lease right of use assets	$	16,370
Operating lease liabilities (1)	16,050

Weighted-average remaining lease term (in years)
Operating leases	6.54

Weighted-average discount rate
Operating leases	4.1		%

(1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in ~~$9.8~~$11.5 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the condensed consolidated balance sheet.

Other information related to leases was as follows (in thousands):

Three-Month Period Ended Six-Month Period Ended
December 28, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases $ 1,180
$ 2,301

Three Months Ended

September 26, 2020

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases

1,198

Future lease payments under non-cancellable leases as of ~~December 28, 2019~~September 26, 2020 are as follows (in thousands):


Fiscal Years Ending	Operating Leases
2021 (1)	$	3,073
2022	3,373
2023	2,598
2024	2,004
2025	1,894
Thereafter	5,673
Total undiscounted lease payments	18,615
Less: present value discount	(2,565)
Total lease liabilities	$	16,050

Fiscal Years Ending Operating Leases
2020 ⁽¹⁾
$ 2,241
2021 3,970
2022 3,371
2023 2,597
2024 1,595
Thereafter 6,337
Total undiscounted lease payments 20,111
Less: present value discount 5,782
Total lease liabilities $ 14,329

(1) Represents estimated lease payments for the remaining ~~six-month~~nine-month period ending ~~June 27, 2020.~~

As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019 and under the previous lease accounting standard ASC 840, the aggregate future minimum payments under non-cancellable operating leases, as of June 29, 2019, are as follows (in thousands):

July 3, 2021.

Fiscal Years Ending Operating Leases
2020 $ 4,777
2021 3,563
2022 2,641
2023 1,866
2024 1,271
Thereafter 4,121
Total minimum lease payments $ 18,239

Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS

References in this report to “the Company,” “Key Tronic,~~” “KeyTronicEMS,~~” “we,” “our,” or “us” mean Key Tronic Corporation together with its subsidiaries, except where the context otherwise requires.

This Quarterly Report contains forward-looking statements in addition to historical information. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties that might cause such differences include, but are not limited to those outlined in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Risks and Uncertainties that May Affect Future Results.” Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s opinions only as of the date hereof. The Company undertakes no obligation to update forward-looking statements to reflect developments or information obtained after the date hereof and disclaims any obligation to do so. Readers should carefully review the risk factors described in periodic reports the Company files from time to time with the Securities and Exchange Commission, including Year-end Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Overview

~~KeyTronicEMS~~Key Tronic is a ~~leader in electronic~~leading contract manufacturer offering value-added design and manufacturing services ~~(EMS)~~from its facilities in the United States, Mexico, China and solutions to original equipment manufacturers of a broad range of products including consumer products, communications, medical, defense, automotive, electronics, gaming, industrial and computer markets. We provideVietnam. The Company provides its customers full engineering services, ~~worldwide procurement and distribution,~~ materials management, ~~world-class~~worldwide manufacturing ~~and~~facilities, assembly services, in-house testing, and ~~unparalleled customer service.~~worldwide distribution. Its customers include some of the world’s leading original equipment manufacturers. Our combined capabilities and vertical integration are proving to be a desirable offering to our expanded customer base.

Our international production capability provides our customers with benefits of improved supply-chain management, reduced inventories, lower transportation costs, and reduced product fulfillment time. We continue to make investments in all of our operating facilities to give us the production capacity, capabilities and logistical advantages to continue to win new business. The following information should be read in conjunction with the consolidated financial statements included herein and with Part II Item 1A, Risk Factors included as part of this filing.

Our mission is to provide our customers with superior manufacturing and engineering services at the lowest total cost for the highest quality products, and create long-term mutually beneficial business relationships by employing our “Trust, Commitment, Results” philosophy.

Executive Summary

For the ~~second~~first quarter of fiscal year ~~2020,~~2021, the Company reported total revenue of ~~$116.7~~$123.2 million, ~~compared to $123.0~~up 17% from $105.3 million in the same period of fiscal year ~~2019.~~2020.

During the ~~second~~first quarter of fiscal ~~2020,~~2021, we ~~continued to win significant new business from EMS competitors and from existing customers, including~~won new programs involving ~~consumer medical devices, Wi-Fi enabled signage~~audio and ~~temperature control devices.~~

~~To prepare for growth in coming quarters, we continue to invest in new capacity in our Mexico, US~~video editing systems, indoor air quality, utility meters, warehouse management, and ~~new Vietnam facilities, including a significant increase in our sheet metal capacity to address demand. We remain optimistic about our opportunities for growth in fiscal 2020 and beyond.~~automation technologies.

The concentration of our top three customers’ net sales ~~increased~~decreased slightly to ~~37.0~~36.8 percent of total sales in the ~~second~~first quarter of fiscal year ~~2020~~2021 from ~~36.6~~37.0 percent in the same period of the prior fiscal year.

Net sales to our largest customers may vary significantly from quarter to quarter depending on the size and timing of customer program commencement, forecasts, delays, and design modifications. We remain dependent on continued net sales to our significant customers and most contracts with customers are not firm long-term purchase commitments. We seek to maintain flexibility in production capacity by employing skilled temporary and short-term labor and by utilizing short-term leases on equipment and manufacturing facilities. In addition, our capacity and core competencies for printed circuit board assemblies, precision molding, sheet metal fabrication, tool making, assembly, and engineering can be applied to a wide variety of products.

Gross profit as a percent of net sales was ~~7.0~~8.1 percent for the ~~second~~first quarter of fiscal year ~~2020~~2021 as compared to ~~8.0~~8.8 percent for the same quarter of the prior fiscal year. The decrease in gross profit as a percentage of net sales was primarily a result of ~~increased factory spend~~additional costs caused by the COVID-19 crisis. These expenses are related to ~~ramping production~~increased compensation at the Company’s Juarez facility in ~~Juarez~~order to reduce turnover of available employees, as well as preventative measures and ~~Vietnam during~~equipment for employees at all of its facilities in the ~~quarter.~~

US, Mexico, China and Vietnam.

Operating income as a percentage of net sales was ~~1.3~~2.3 percent for the ~~second~~first quarter of fiscal year ~~2020~~2021 compared to ~~2.1~~2.4 percent of operating income as a percentage of net sales for the ~~second~~first quarter of fiscal year ~~2019.~~2020. The decrease in operating income as a percentage of net sales was primarily driven by increased ~~factory spend~~expenses related to ~~ramping production in Juarez and Vietnam during~~ the ~~quarter.~~COVID-19 pandemic as discussed above.

Net income for the ~~second~~first quarter of fiscal year ~~2020~~2021 was ~~$0.8~~$1.7 million or ~~$0.08~~$0.16 per share, as compared to net income of $1.6 million or ~~$0.15~~$0.14 per share for the first quarter of fiscal year 2020.

We’re pleased with the successful launch of new programs, rebounding customer demand and our strong revenue growth in the first quarter of fiscal 2021. We are ramping recent program wins and, while some of our legacy customers continued to have reduced demand due to the pandemic and related economic slowdown, several have increased demand during the first quarter of fiscal 2021, including programs for healthcare, industrial controls, and telecommunications.During the first quarter of fiscal 2021, we won new programs involving audio and video editing systems, indoor air quality, utility meters, warehouse management, and automation technologies.

Moving into the second quarter of fiscal ~~year 2019.~~

~~As previously noted,~~2021, the ~~lower than anticipated earnings for~~COVID-19 crisis continues to present macroeconomic uncertainty and multiple business challenges, but we continue to see the favorable trend of contract manufacturing returning to North America. We remain focused on protecting the health of all of our employees by adhering to current health guidelines, as well as increasing retention of available employees. We expect continued strong revenue growth in the second quarter ~~of fiscal 2020 was primarily a result of increased factory spending~~and continue to invest in ~~the Company’s Juarez metal fabrication departments. This spending was necessitated by both~~ new and existing customers exiting their manufacturing arrangements in China and ramping their production in Juarez. While the financial effect on Key Tronic was significant, the long-term relationship with these customers was strengthened by the performance of the Juarez facility under extreme pressure. Additionally, the Company incurred unfavorable foreign currency losses relatedcapacity to ~~its unhedged portion of Mexican labor expenses due to a strengthening peso over the quarter.~~

Our pipeline of potential new business is also increasingly robust, involving programs with greater long-term revenue potential and higher quantity requirements. Our increased competitiveness in the EMS marketplace is being driven by the growing recognition of the advantages of North American and Vietnam based production, opportunities presented by the acquisition of Ayrshire, as well as by the growing number of opportunities where we can capitalize on the continued expansion of our sheet metal fabrication capabilities in concert with our plastic molding, printed circuit, and product assembly capabilities. We believe that we are well positioned in the EMS industry to continue expansion of our customer base and achieveprepare for long-term growth.

~~For the third quarter of fiscal year~~On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The Company ~~expects~~is continuing to ~~report revenue in~~evaluate the ~~range~~CARES Act, and at this time does not believe it will have a material impact on our consolidated financial position, results of ~~$117 million~~operations, or cash flows. Refer to $122 million. These expected results assume an effective tax rate of 20% in the quarter. Future results will depend on actual levels of customers’ orders and the timing of the startup of production of new product programs.footnote 6 Income Taxes for discussion.

We maintain a strong balance sheet with a current ratio of ~~2.0~~2.5 and a debt to equity ratio of ~~0.4~~0.7 as of ~~December 28, 2019.~~September 26, 2020. Total cash used in operating activities as defined on our cash flow statement was ~~$8.4~~$9.4 million for the ~~six~~three months ended ~~December 28, 2019.~~September 26, 2020. We maintain sufficient liquidity for our expected future operations and had ~~$32.0~~$80.7 million in borrowings on our ~~$55.0 million~~ revolving ~~line of~~ credit ~~with Wells Fargo Bank, N.A.~~facility of which ~~$22.6~~$12.3 million remained available at ~~December 28, 2019. We believe cash flows generated from operations, our borrowing capacity, and leasing opportunities should provide adequate capital for planned growth.~~September 26, 2020.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. These estimates and assumptions are based on historical results as well as future expectations. Actual results could vary from our estimates and assumptions.

The accounting policies and estimates listed below are those that we believe are the most critical to our consolidated financial condition and results of operations. They are also the accounting policies that typically require our most difficult, subjective and complex judgments and estimates, often for matters that are inherently uncertain.

•Revenue Recognition

•Inactive, Obsolete, and Surplus Inventory Reserve

•Allowance for Doubtful Accounts

•Accrued Warranty

•Income Taxes

•Share-Based Compensation

•Impairment of Long-Lived Assets

•Derivatives and Hedging Activity

•Long-Term Incentive Compensation Accrual

•Impairment of Goodwill

Please refer to the discussion of critical accounting policies in our most recent Annual Report on Form 10-K for the fiscal year ended June ~~29, 2019,~~27, 2020, for further details. ~~There were no changes to our accounting policies other than the adoption of ASC 842 as follows:~~

~~Leases~~

~~Refer to footnote 2 Significant Accounting Policies and footnote 14 Leases for critical accounting policies related to the adoption of ASC 842.~~

RESULTS OF OPERATIONS

Comparison of the Three Months Ended ~~December 28, 2019~~September 26, 2020 with the Three Months Ended ~~December 29, 2018~~September 28, 2019

The financial information and discussion below should be read in conjunction with the Consolidated Financial Statements and Notes.

The following table sets forth certain information regarding the components of our condensed consolidated statements of income for the three months ended ~~December 28, 2019~~September 26, 2020 as compared to the three months ended ~~December 29, 2018~~.September 28, 2019. It is provided to assist in assessing differences in our overall performance (in thousands):


	Three Months Ended																Three Months Ended
	December 28, 2019			% of net sales		December 29, 2018			% of net sales		$ change			% point change			September 26, 2020			% of net sales		September 28, 2019			% of net sales		$ change		% point change
Net sales	$	116,722		100.0	%	$	123,037		100.0	%	$	(6,315	)	—	%	Net sales	$	123,207		100.0	%	$	105,285		100.0	%	$	17,922	—	%
Cost of sales	108,600			93.0	%	113,157			92.0	%	(4,557		)	1.0	%	Cost of sales	113,192			91.9	%	96,012			91.2	%	17,180		0.7	%
Gross profit	8,122			7.0	%	9,880			8.0	%	(1,758		)	(1.0	)%	Gross profit	10,015			8.1	%	9,273			8.8	%	742		(0.7)	%
Research, development and engineering	1,720			1.5	%	1,857			1.5	%	(137		)	—	%	Research, development and engineering	2,245			1.8	%	1,660			1.6	%	585		0.2	%
Selling, general and administrative	4,904			4.2	%	5,399			4.4	%	(495		)	(0.2	)%	Selling, general and administrative	4,974			4.0	%	5,074			4.8	%	(100)		(0.8)	%
Total operating expenses	6,624			5.7	%	7,256			5.9	%	(632		)	(0.2	)%	Total operating expenses	7,219			5.8	%	6,734			6.4	%	485		(0.6)	%
Operating income	1,498			1.3	%	2,624			2.1	%	(1,126		)	(0.8	)%	Operating income	2,796			2.3	%	2,539			2.4	%	257		(0.1)	%
Interest expense, net	524			0.4	%	708			0.6	%	(184		)	(0.2	)%	Interest expense, net	681			0.6	%	710			0.7	%	(29)		(0.1)	%
Income before income taxes	974			0.8	%	1,916			1.6	%	(942		)	(0.8	)%	Income before income taxes	2,115			1.7	%	1,829			1.7	%	286		—	%
Income tax provision	150			0.1	%	327			0.3	%	(177		)	(0.2	)%	Income tax provision	396			0.3	%	277			0.3	%	119		—	%
Net income	$	824		0.7	%	$	1,589		1.3	%	$	(765	)	(0.6	)%	Net income	$	1,719		1.4	%	$	1,552		1.5	%	$	167	(0.1)	%
Effective income tax rate	15.4		%			17.1		%								Effective income tax rate	18.7		%			15.1		%

Net Sales

Net sales of ~~$116.7~~$123.2 million for the ~~second~~first quarter of fiscal year ~~2020 decreased~~2021 increased by ~~5.1~~17.0 percent as compared to net sales of ~~$123.0~~$105.3 million for the ~~second~~first quarter of fiscal year ~~2019.~~2020.

The ~~$6.3~~$17.9 million ~~decrease~~increase in net sales from the prior year period was driven by an increase in ~~the~~ demand for ~~sheet metals causing workload balancing challenges. These constraints resulted~~new program wins and current programs. However, partially offsetting the increase in ~~production delays~~revenue during the first quarter of fiscal year 2021, the Company’s revenue was constrained by labor shortages at its facilities in Juarez due to the COVID-19 pandemic and ~~were the primary reason for the unexpected shortfall in revenue.~~associated public health measures.

Gross Profit

Gross profit as a percentage of net sales for the three months ended ~~December 28, 2019~~September 26, 2020 was ~~7.0~~8.1 percent compared to ~~8.0~~8.8 percent for the three months ended ~~December 29, 2018.~~September 28, 2019. This ~~1.0~~0.7 percentage point decrease was due to ~~increased factory spending~~an increase in ~~the Company’s Juarez metal fabrication departments.~~COVID related expenses.

The level of gross margin is impacted by facility utilization, product mix, timing, severity and steepness of new program ramps, pricing within the electronics industry and material costs, which can fluctuate significantly from quarter to quarter.

Included in gross profit are charges related to changes in the allowance for obsolete inventory. We recorded a provision of approximately ~~$20,000~~$178,000 and ~~$45,000~~$21,000 for obsolete inventory during the three months ended ~~December~~September 26, 2020 and September 28, 2019, ~~and December 29, 2018,~~ respectively. We adjust the allowance for estimated obsolescence as necessary in an amount equal to the difference between the cost of inventory and estimated net realizable value based on assumptions as to future demand and market conditions. The reserves are established for inventory that we have determined customers are not contractually responsible for and for inventory that we believe customers will be unable to purchase.

Operating Expenses

Total research, development, and engineering (RD&E) expenses were $2.2 million during the three months ended September 26, 2020 and $1.7 million during the three months ended ~~December~~September 28, 2019, ~~and $1.9 million during the three months ended December 29, 2018,~~ respectively. The increase in RD&E expenses relate to an increase in engineering payroll expenses. Total RD&E expenses as a percent of net sales were ~~1.5~~1.8 percent during the three months ended ~~December 28, 2019~~September 26, 2020 and ~~1.5~~1.6 percent during the three months ended ~~December 29, 2018.~~September 28, 2019.

Total selling, general and administrative (SG&A) expenses were ~~$4.9~~$5.0 million during the three months ended ~~December 28, 2019~~September 26, 2020 compared to ~~$5.4~~$5.1 million for the three months ended ~~December 29, 2018.~~September 28, 2019. Total SG&A expenses for the three months ended September 26, 2020, were favorably impacted by a decrease in travel related expenses due to the COVID-19 pandemic. Total SG&A expenses as a percentage of net sales were ~~4.2~~4.0 percent ~~during~~for the three months ended ~~December 28, 2019 compared to 4.4~~September 26, 2020 and 4.8 percent ~~during~~for the three months ended ~~December 29, 2018. This 0.2 percent decrease in SG&A is related to a decrease in legal fees.~~September 28, 2019.

Interest

Interest expense was ~~$0.5 million during the three months ended December 28, 2019 and~~ $0.7 million during the three months ended ~~December 29, 2018. The decrease in interest expense is primarily related to a decrease in~~September 26, 2020 and the ~~average balance outstanding on our line of credit.~~three months ended September 28, 2019, respectively.

Income Taxes

The effective tax rate for the three months ended ~~December 28, 2019~~September 26, 2020 was ~~15.4~~18.7 percent compared to ~~17.1~~15.1 percent for the three months ended ~~December 29, 2018.~~September 28, 2019. The ~~decrease~~increase was primarily due to ~~the recognition of certain discrete adjustments associated with U.S.~~reduced federal research and development tax ~~reform that were recorded~~credits in the ~~prior year, offset by the impact of taxation in foreign jurisdictions.~~three months ended September 26, 2020. For further information on taxes see footnote 6 of the “Notes to Consolidated Financial Statements.”

Our judgments regarding deferred tax assets and liabilities may change due to changes in market conditions, changes in estimates, changes in tax laws or other factors. If assumptions and estimates change in the future the deferred tax assets and liability will be adjusted accordingly and any increase or decrease will result in an additional deferred income tax expense or benefit in subsequent periods.

~~RESULTS OF OPERATIONS~~

~~Comparison of the Six Months Ended December 28, 2019 with the Six Months Ended December 29, 2018~~

~~The financial information and discussion below should be read in conjunction with the Consolidated Financial Statements and Notes.~~

The following table sets forth certain information regarding the components of our condensed consolidated statements of income (loss) for the six months ended December 28, 2019 as compared to the six months ended December 29, 2018. It is provided to assist in assessing differences in our overall performance (in thousands):

Six Months Ended
December 28, 2019 % of
net sales December 29, 2018 % of
net sales $ change % point
change
Net sales $ 222,007
100.0 % $ 250,509
100.0 % $ (28,502 ) — %
Cost of sales 204,612
92.2 % 231,096
92.3 % (26,484 ) (0.1 )%
Gross profit 17,395
7.8 % 19,413
7.7 % (2,018 ) 0.1 %
Research, development and engineering 3,380
1.5 % 3,557
1.4 % (177 ) 0.1 %
Selling, general and administrative 9,978
4.5 % 10,687
4.3 % (709 ) 0.2 %
Impairment of goodwill and intangibles —
— % —
— % —
— %
Total operating expenses 13,358
6.0 % 14,244
5.7 % (886 ) 0.3 %
Operating income 4,037
1.8 % 5,169
2.1 % (1,132 ) (0.3 )%
Interest expense, net 1,234
0.6 % 1,385
0.6 % (151 ) — %
Income before income taxes 2,803
1.3 % 3,784
1.5 % (981 ) (0.2 )%
Income tax provision 427
0.2 % 602
0.2 % (175 ) — %
Net income $ 2,376
1.1 % $ 3,182
1.3 % $ (806 ) (0.2 )%
Effective income tax rate 15.2 % 15.9 %

~~Net Sales~~

~~Net sales of $222.0 million for the six months ended December 28, 2019 decreased by 11.4 percent as compared to net sales of $250.5 million for the six months ended December 29, 2018.~~

The $28.5 million decrease in net sales from the prior year period was primarily driven by an increase in the demand for sheet metals causing workload balancing challenges. These constraints resulted in production delays and were the primary reason for the unexpected shortfall in revenue.

~~Gross Profit~~

Gross profit as a percentage of net sales for the six months ended December 28, 2019 was 7.8 percent compared to 7.7 percent for the six months ended December 29, 2018. This 0.1 percentage point decrease is primarily related to a decrease in certain overhead costs partially offset by an increase in material related costs. The level of gross margin is impacted by facility utilization, product mix, timing, severity and steepness of new program ramps, pricing within the electronics industry and material costs, which can fluctuate significantly from quarter to quarter.

Included in gross profit are charges related to changes in the allowance for obsolete inventory. We recorded a provision of approximately $41,000 and $58,000 for obsolete inventory during the six months ended December 28, 2019 and December 29, 2018, respectively. We adjust the allowance for estimated obsolescence as necessary in an amount equal to the difference between the cost of inventory and estimated market value based on assumptions as to future demand and market conditions. The reserves are established for inventory that we have determined customers are not contractually responsible for and for inventory that we believe customers will be unable to purchase.

~~Operating Expenses~~

Total research, development, and engineering (RD&E) expenses were $3.4 million and $3.6 million during the six months ended December 28, 2019 and December 29, 2018, respectively. Total RD&E expenses as a percent of net sales were 1.5 percent during the six months ended December 28, 2019 and the six months ended December 29, 2018.

Total selling, general and administrative (SG&A) expenses were $10.0 million during the six months ended December 28, 2019 compare to $10.7 million for the nine months ended December 29, 2018. Total SG&A expenses as a percentage of net sales were 4.5 percent during the six months ended December 28, 2019 compared to 4.3 percent during the six months ended December 29, 2018. This 0.2 percentage point increase in SG&A is related to an increase in professional fees and commission expense.

~~Interest~~

Interest expense was $1.2 million during the six months ended December 28, 2019 compared to $1.4 million during the six months ended December 29, 2018. The decrease in interest expense is primarily related to a decrease in the average balance outstanding on our line of credit.

~~Income Taxes~~

The effective tax rate for the six months ended December 28, 2019 was 15.2 percent compared to 15.9 percent for the same period in fiscal year 2019. The effective tax rate decreased from the prior year primarily due to the recognition of certain discrete adjustments associated with U.S. tax reform that were recorded in the prior year, offset by the impact of taxation in foreign jurisdictions. For further information on taxes see footnote 6 of the “Notes to Consolidated Financial Statements.” Refer to footnote 12 for additional information relating to the write-off of certain intangible assets.

BACKLOG

On ~~December 28, 2019,~~September 26, 2020, we had an order backlog of approximately ~~$145.5~~$201.9 million. This compares with a backlog of approximately ~~$151.2~~$159.9 million on ~~December 29, 2018.~~September 28, 2019. The increase in order backlog was related to the effect of the COVID-19 pandemic on our customer’s demand resulting in a net positive, as the Company saw increases in demand from programs for home-consumer products, healthcare and home exercise equipment. Order backlog consists of purchase orders received for products expected to be shipped within the next 12 months, although shipment dates are subject to change due to design modifications or changes in other customer requirements. Order backlog should not be considered an accurate measure of future net sales.

CAPITAL RESOURCES AND LIQUIDITY

Operating Cash Flow

Net cash used in operating activities for the ~~six~~three months ended ~~December 28, 2019~~September 26, 2020 was ~~$8.4~~$9.4 million, compared to ~~net cash used in operating activities of $5.1~~$10.3 million during the same period of the prior fiscal year.

The ~~$8.4~~$9.4 million of net cash used in operating activities for the ~~six~~three months ended ~~December 28, 2019~~September 26, 2020 is primarily related to ~~$2.4~~$1.7 million in net income for the period adjusted for ~~$3.1~~$1.8 million of depreciation and amortization, a ~~$6.9~~$5.4 million increase in accounts ~~payable, $5.1 million decrease in contract assets, offset by~~receivable, a ~~$9.8~~$4.9 million increase in inventory, a $2.8 million decrease in accrued compensation and vacation, a ~~$13.5~~$1.1 million decrease in accounts payable, $0.7 million increase in contract assets. The $5.4 million increase in accounts ~~receivable.~~receivable is a direct result of the Company not factoring receivables during the first quarter fiscal year 2021.

~~This compares to $5.1~~The $10.3 million of net cash used in operating activities for the ~~six~~three months ended ~~December 29, 2018~~September 28, 2019 is primarily related to ~~$3.2~~$1.6 million in net income for the period adjusted for ~~$3.8~~$1.6 million of depreciation and amortization, ~~$6.7 million of cash received from arbitration settlement,~~ a ~~$7.4 million decrease in inventory, partially offset by a $3.1 million decrease in accounts payable, $7.2 million increase in contract assets, a $2.0~~$13.6 million increase in accounts ~~receivable, a $5.0 million increase in other assets, and a~~payable, $0.4 million decrease in ~~accrued compensation.~~contract assets, offset by a $17.3 million increase in inventory and a $10.1 million increase in accounts receivable.

Accounts receivable fluctuates based on the timing of shipments, terms offered and collections that occurred during the quarter. While overall net sales are not typically seasonal in nature, we ship the majority of our product during the latter half of the quarter. In addition, accounts receivable will fluctuate based upon the amount of accounts receivable sold under our trade accounts receivable purchase programs. During the ~~six~~three months ended ~~December~~September 26, 2020, the Company did not factor any accounts receivable. During the three months ended September 28, 2019, ~~and December 29, 2018,~~ we factored accounts receivable of ~~$35.0~~$17.8 million, ~~and $41.1 million, respectively,~~ which were removed from our Consolidated Balance Sheets. The $17.8 million year over year decrease in factored receivables is a direct result of the Company not factoring receivables during the first quarter fiscal year 2021. We purchase inventory based on customer forecasts and orders, and when those forecasts and orders change, the amount of inventory may also fluctuate. Accounts payable fluctuates with changes in inventory levels, volume of inventory purchases, ~~and~~ negotiated supplier ~~terms.~~terms and taking advantage of early pay discounts.

Investing Cash Flow

Cash used in investing activities was ~~$2.0~~$3.2 million during the ~~six~~three months ended ~~December 28, 2019~~September 26, 2020 as compared to ~~cash used in investing activities of $0.3~~$1.3 million during the ~~six~~three months ended ~~December 29, 2018.~~September 28, 2019. Our primary investing activity during the ~~six~~three months ended ~~December~~September 26, 2020 and September 28, 2019, ~~and December 29, 2018,~~ was purchasing equipment to support increased production levels for new programs.

Leases are often utilized when potential technical obsolescence and funding requirement advantages outweigh the benefits of equipment ownership. Capital expenditures and periodic lease payments are expected to be financed with internally generated funds as well as our revolving line of credit facility and equipment term loan.

Financing Cash Flow

Cash provided by financing activities was ~~$10.3~~$13.5 million during the ~~six~~three months ended ~~December 28, 2019~~September 26, 2020 as compared to ~~cash provided by financing activities of $5.2~~$11.5 million in the same period of the previous fiscal year. Our primary financing activities during the ~~six~~three months ended ~~December~~September 26, 2020 and three months ended September 28, 2019, ~~and six months ended December 29, 2018,~~ were borrowings and repayments under our revolving line of credit facility and term loans. ~~Our credit agreement with Wells Fargo Bank N.A. provides a revolving line of credit facility of up to $55.0 million, subject to availability.~~

As of ~~December~~September 26, 2020, approximately $12.3 million was available under the asset-based revolving credit facility. As of September 28, 2019, approximately ~~$22.6~~$13.3 million was available under the revolving line of credit ~~facility. As of December 29, 2018, approximately $20.2 million was available under the revolving line of credit facility.~~facility with Wells Fargo Bank.

Our cash requirements are affected by the level of current operations and new ~~EMS~~ programs. We believe that projected cash from operations, funds available under the revolving credit facility and leasing capabilities will be sufficient to meet our working and fixed capital requirements for the foreseeable future. The Company further notes the positive impact of COVID-19 on projected cash from operations from increased demand from certain customers will be partially offset by an anticipated slowdown in collections from others. As of ~~December 28, 2019,~~September 26, 2020, we had approximately ~~$500,000~~$825,000 of cash held by foreign subsidiaries. If cash is to be repatriated in the future from these foreign subsidiaries, the Company would be subject to certain withholding taxes in the foreign jurisdictions. The total amount of tax payments required for the amount of foreign subsidiary cash on hand as of ~~December 28, 2019~~September 26, 2020 would approximate ~~$38,000.~~$42,000. We have accrued withholding taxes for expected future repatriation of foreign earnings as discussed in footnote 6 of the “Notes to Consolidated Financial Statements.”

OFF-BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

We have included a summary of our Contractual Obligations in our annual report on Form 10-K for the fiscal year ended June ~~29, 2019.~~27, 2020. There have been no material changes in contractual obligations outside the ordinary course of business since June ~~29, 2019.~~27, 2020.

RISKS AND UNCERTAINTIES THAT MAY AFFECT FUTURE RESULTS

The following risks and uncertainties could affect our actual results and could cause results to differ materially from past results or those contemplated by our forward-looking statements. When used herein, the words “expects,” “believes,” “anticipates” and other similar expressions are intended to identify forward-looking statements.

Our operations may be subject to certain risks.

We manufacture product in facilities located in Mexico, China, Vietnam and the United States. These operations may be subject to a number of risks, including:

•difficulties in staffing, turnover and managing onshore and offshore operations;

•political and economic instability (including acts of terrorism, pandemics, civil unrest, forms of violence and outbreaks of war), which could impact our ability to ship, manufacture, and/or receive product;

•unexpected changes in regulatory requirements and laws;

•longer customer payment cycles and difficulty collecting accounts receivable;

•export duties, import controls and trade barriers (including quotas);

•governmental restrictions on the transfer of funds;

•burdens of complying with a wide variety of foreign laws and labor practices; subject to trade wars and tariffs

•our locations may be impacted by hurricanes, tornadoes, earthquakes, water shortages, tsunamis, floods, typhoons, fires, extreme weather conditions and other natural or man-made disasters. Our locations may also be impacted by future temporary closures and labor constraints as a result of COVID-19.

Our operations in certain foreign locations receive favorable income tax treatment in the form of tax credits or other incentives. In the event that such tax incentives are not extended, are repealed, or we no longer qualify for such programs, our taxes may increase, which would reduce our net income.

Additionally, certain foreign jurisdictions restrict the amount of cash that can be transferred to the U.S or impose taxes and penalties on such transfers of cash. To the extent we have excess cash in foreign locations that could be used in, or is needed by, our operations in the United States, we may incur significant penalties and/or taxes to repatriate these funds.

We may experience fluctuations in quarterly results of operations.

Our quarterly operating results have varied in the past and may vary in the future due to a variety of factors, including adverse changes in the U.S. and global macroeconomic environment, volatility in overall demand for our customers’ products, success of customers’ programs, timing of new programs, new product introductions or technological advances by us, our customers and our competitors, and changes in pricing policies by us, our customers, our suppliers, and our competitors. Our customer base is diverse in the markets they serve, however, decreases in demand, particularly from customers in certain industries could affect future quarterly results. Additionally, our customers could be adversely impacted by illiquidity in the credit markets which could directly impact our operating results.

Component procurement, production schedules, personnel and other resource requirements are based on estimates of customer requirements. Occasionally, our customers may request accelerated production that can stress resources and reduce operating margins. Conversely, our customers may abruptly lower or cancel production which may lead to a sudden, unexpected increase in inventory or accounts receivable for which we may not be reimbursed even when under contract with customers. In addition, because many of our operating expenses are relatively fixed, a reduction in customer demand can harm our gross profit and operating results. The products which we manufacture for our customers have relatively short product lifecycles. Therefore, our business, operating results and financial condition are dependent in a significant way on our ability to obtain orders from new customers and new product programs from existing customers.

Operating results can also fluctuate if changes are made to significant estimates and assumptions. Significant estimates and assumptions include the allowance for doubtful receivables, provision for obsolete and non-saleable inventory, stock-based compensation, the valuation allowance on deferred tax assets, impairment of long-lived assets, long-term incentive compensation accrual, the provision for warranty costs, and the impact of hedging activities.

Due to the COVID-19 pandemic, we have seen extreme shifts in demand from our customer base. The possibility of future temporary closures and labor constraints, as well as the inability to predict customer demand, costs, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results.

We are exposed to general economic conditions, which could have a material adverse impact on our business, operating results and financial condition.

Adverse economic conditions and uncertainty in the global economy such as unstable global financial and credit markets, inflation, and recession can negatively impact our business. Unfavorable economic conditions could affect the demand for our customers’ products by triggering a reduction in orders as well as a decline in forecasts which could adversely affect our sales in future periods. Additionally, the financial strength of our customers and suppliers and their ability to obtain and rely on credit financing may affect their ability to fulfill their obligations to us and have an adverse effect on our financial results.

Adverse macroeconomic conditions as a result of COVID-19 can affect our business. The conditions can affect the Company’s ability to predict and plan for future supply chain disruptions, fluctuations in customer demand and costs, and the ability to operate as there is uncertainty over future temporary closures.

The majority of our sales come from a small number of customers and a decline in sales to any of these customers could adversely affect our business.

At present, our customer base is concentrated and could become more or less concentrated. There can be no assurance that our principal customers will continue to purchase products from us at current levels. Moreover, we typically do not enter into long-term volume purchase contracts with our customers, and our customers have certain rights to extend or delay the shipment of their orders. We, however, typically require that our customers contractually agree to buy back inventory purchased within specified lead times to build their products if not used.

The loss of one or more of our major customers, or the reduction, delay or cancellation of orders from such customers, due to economic conditions or other forces, could materially and adversely affect our business, operating results and financial condition. The contraction in demand from certain industries could impact our customer orders and have a negative impact on our operations over the foreseeable future. Additionally, if one or more of our customers were to become insolvent or otherwise unable to pay for the manufacturing services provided by us, our operating results and financial condition would be adversely affected.

We depend on a limited number of suppliers for certain components that are critical to our manufacturing processes. A shortage of these components or an increase in their price could interrupt our operations and result in a significant change in our results of operations.

We are dependent on many suppliers, including sole source suppliers, to provide key components and raw materials used in manufacturing customers’ products. We have seen supply shortages in certain electronic components. In addition, our suppliers' facilities may also experience earthquakes, tsunamis and other natural disasters which may cause a shortage of components. This can result in longer lead times and the inability to meet our customers request for flexible production and extended shipment dates. If demand for components outpaces supply, capacity delays could affect future operations. Delays in deliveries from suppliers or the inability to obtain sufficient quantities of components and raw materials could cause delays or reductions in shipment of products to our customers which could adversely affect our operating results and damage customer relationships.

Key Tronic is working closely with its employees and key suppliers to ascertain delays attributable to the ~~recent outbreak of coronavirus in China.~~COVID-19 pandemic. Potential delays in production and extended transit times of critical parts ~~could~~ may cause a shortage of components.

We operate in a highly competitive industry; if we are not able to compete effectively in the EMS industry, our business could be adversely affected.

Competitors may offer customers lower prices on certain high volume programs. This could result in price reductions, reduced margins and loss of market share, all of which would materially and adversely affect our business, operating results, and financial condition. If we were unable to provide comparable or better manufacturing services at a lower cost than our competitors, it could cause sales to decline. In addition, competitors can copy our non-proprietary designs and processes after we have invested in development of products for customers, thereby enabling such competitors to offer lower prices on such products due to savings in development costs.

Cash and cash equivalents are exposed to concentrations of credit risk.

We place our cash with high credit quality institutions. At times, such balances may be in excess of the federal depository insurance limit or may be on deposit at institutions which are not covered by insurance. If such institutions were to become insolvent during which time it held our cash and cash equivalents in excess of the insurance limit, it could be necessary to obtain other credit financing to operate our facilities.

Our ability to secure and maintain sufficient credit arrangements is key to our continued operations.

There is no assurance that we will be able to retain or renew our credit agreements in the future. In the event the business grows rapidly or there is uncertainty in the macroeconomic climate, additional financing resources could be necessary in the current or future fiscal years. There is no assurance that we will be able to obtain equity or debt financing at acceptable terms, or at all in the future. In addition, we have restrictive covenants with our financial institution which could impact how we manage our business. If we cannot meet our financial covenants, our borrowings could become immediately payable which could have a material adverse impact on our financial statements. For a summary of our banking arrangements, see Note 4 Long-Term Debt of the “Notes to Consolidated Financial Statements.”

~~Our operations may be subject to certain risks.~~

~~We manufacture product in facilities located in Mexico, China and the United States. These operations may be subject to a number of risks, including:~~

~~difficulties in staffing, turnover and managing onshore and offshore operations;~~

political and economic instability (including acts of terrorism, pandemics, civil unrest, forms of violence and outbreaks of war), which could impact our ability to ship, manufacture, and/or receive product;

~~unexpected changes in regulatory requirements and laws;~~

~~longer customer payment cycles and difficulty collecting accounts receivable;~~

~~export duties, import controls and trade barriers (including quotas);~~

~~governmental restrictions on the transfer of funds;~~

~~burdens of complying with a wide variety of foreign laws and labor practices;~~

~~our locations may be impacted by hurricanes, tornadoes, earthquakes, water shortages, tsunamis, floods, typhoons, fires, extreme weather conditions and other natural or man-made disasters.~~

Fluctuations in foreign currency exchange rates could increase our operating costs.

We have manufacturing operations located in Mexico, China and ~~China.~~Vietnam. A ~~significant~~ portion of our operations are denominated in the Mexican peso, ~~and~~ the Chinese ~~currency, the~~ renminbi ~~("RMB")~~(RMB) and Vietnamese dong (VND). Currency exchange rates fluctuate daily as a result of a number of factors, including changes in a country's political and economic policies. Volatility in the currencies of our entities and the United States dollar could seriously harm our business, operating results and financial condition. The primary impact of currency exchange fluctuations is on the cash, receivables, payables and expenses of our operating entities. As part of our hedging strategy, we currently use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. We currently do not hedge expenses denominated in ~~RMB.~~RMB or VND. Unexpected losses could occur from increases in the value of these currencies relative to the United States dollar.

As a result of COVID-19, significant currency exchange fluctuations can occur causing unexpected losses. Future temporary closures of production facilities in Mexico could also cause significant changes in our ability to qualify for hedge accounting treatment of our forward contracts to hedge foreign currency fluctuations. However, given the unprecedented nature of the pandemic the FASB staff believes that an entity may apply the exception in paragraph 815-30-40-4 for rare cases caused by extenuating circumstances that are related to the nature of the forecasted transaction and are outside the control or influence of an entity to delays in the timing of the forecasted transactions if those delays are related to the effects of the COVID-19 pandemic and are considered probable to still occur. In addition, the FASB staff believes that it would be acceptable for an entity to determine that missed forecasts related to the effects of the COVID-19 pandemic need not be considered when determining whether it has exhibited a pattern of missing forecasts that would call into question its ability to accurately predict forecasted transactions and the propriety of using cash flow hedge accounting in the future for similar transactions.

Our success will continue to depend to a significant extent on our key personnel.

Our future success depends in large part on the continued service of our key technical, marketing and management personnel and on our ability to continue to attract and retain qualified production employees. There can be no assurance that we will be successful in attracting and retaining such personnel, particularly in our manufacturing locales that may be experiencing high demand for similar key personnel. The loss of key employees could have a material adverse effect on our business, operating results and financial condition.

If we are unable to maintain our technological and manufacturing process expertise, our business could be adversely affected.

The markets for our customers’ products are characterized by rapidly changing technology, evolving industry standards, frequent new product introductions and short product life cycles. The introduction of products embodying new technologies or the emergence of new industry standards can render existing products obsolete or unmarketable. Our success will depend upon our customers’ ability to enhance existing products and to develop and introduce, on a timely and cost-effective basis, new products that keep pace with technological developments and emerging industry standards and address evolving and increasingly sophisticated customer requirements. Failure of our customers to do so could substantially harm our customers’ competitive positions. There can be no assurance that our customers will be successful in identifying, developing and marketing products that respond to technological change, emerging industry standards or evolving customer requirements.

Start-up costs and inefficiencies related to new or transferred programs can adversely affect our operating results and such costs may not be recoverable if such new programs or transferred programs are canceled or don’t meet expected sales volumes.

Start-up costs, the management of labor and equipment resources in connection with the establishment of new programs and new customer relationships, and the need to obtain required resources in advance can adversely affect our gross margins and operating results. These factors are particularly evident in the ramping stages of new programs. These factors also affect our ability to efficiently use labor and equipment. We are currently managing a number of new programs. Consequently, our exposure to these factors has increased. In addition, if any of these new programs or new customer relationships were terminated, our operating results could be harmed, particularly in the short term. We may not be able to recoup these start-up costs or replace anticipated new program revenues.

Customers may change production timing and demand schedules which makes it difficult for us to schedule production and capital expenditures and to maximize the efficiency of our manufacturing capacity.

Changes in demand for customer products reduce our ability to accurately estimate the future requirements of our customers. This makes it difficult to schedule production and maximize utilization of our manufacturing capacity. We must determine the levels of business that we will seek and accept from customers, set production schedules, commit to procuring inventory, and allocate personnel and resources, based on our estimates of our customers' requirements. Customers can require sudden increases and decreases in production which can put added stress on resources and reduce margins. Sudden decreases in production can lead to excess inventory on hand which may or may not be reimbursed by our customers even when under contract.

Continued growth could further lead to capacity constraints. We may need to transfer production to other facilities, acquire new facilities, or outsource production which could negatively impact gross margin.

The Company has been able to manage the arrival of components in an effort to control inventory levels of customers that have seen sharp decreases in demand, as a result of COVID-19.

An adverse change in the interest rates for our borrowings could adversely affect our financial condition.

We are exposed to interest rate risk under our revolving line of credit and term loan. We currently hedge a portion of our term loan with an interest rate swap. We have not historically hedged the interest rate on our credit facility; therefore, unless we do so, significant changes in interest rates could adversely affect our results of operations. Refer to the discussion in note 4, "Long-Term Debt" to the consolidated financial statements for further details of our debt obligations. ~~We are also exposed to interest rate risk on our factoring activities.~~

Compliance or the failure to comply with current and future environmental and health laws or regulations could cause us significant expense.

We are subject to a variety of domestic and foreign environmental regulations relating to the use, storage, and disposal of materials used in our manufacturing processes. If we fail to comply with any present or future regulations, we could be subject to future liabilities or the suspension of current manufacturing operations. In addition, such regulations could restrict our ability to expand our operations or could require us to acquire costly equipment, substitute materials, or incur other significant expenses to comply with government regulations.

To protect the health of its employees, the Company has implemented the recommendations of WHO and the CDC including wearing of face masks and shields, workstation arrangements to provide social distancing, temperature monitoring, enhanced worksite disinfection, spacing in cafeterias and break areas, contact management and other precautions. The Company is also in compliance with government regulations related to COVID-19.

Our stock price is volatile.

Holders of the common stock will suffer immediate dilution to the extent outstanding equity awards are exercised to purchase common stock. Our stock price may be subject to wide fluctuations and possible rapid increases or declines over a short time period. These fluctuations may be due to factors specific to us such as our stock's thinly traded nature, variations in quarterly operating results or changes in earnings estimates, or to factors relating to the EMS industry or to the securities markets in general, which, in recent years, have experienced significant price fluctuations. These fluctuations often have been unrelated to the operating performance of the specific companies whose stocks are traded.

Due to inherent limitations, there can be no assurance that our system of disclosure and internal controls and procedures will be successful in preventing all errors, theft and fraud, or in informing management of all material information in a timely manner.

Management does not expect that our disclosure controls and internal controls and procedures will prevent all errors or fraud. A control system is designed to give reasonable, but not absolute, assurance that the objectives of the control system are met. In addition, any control system reflects resource constraints and the benefits of controls must be considered relative to their costs. Inherent limitations of a control system may include: judgments in decision making may be faulty, breakdowns can occur simply because of error or mistake and controls can be circumvented by collusion or management override. Due to the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

If we do not manage our growth effectively, our profitability could decline.

Our business is experiencing growth which can place considerable additional demands upon our management team and our operational, financial and management information systems. Our ability to manage growth effectively requires us to continue to implement and improve these systems; avoid cost overruns; maintain customer, supplier and other favorable business relationships during possible transition periods; continue to develop the management skills of our managers and supervisors; and continue to train, motivate and manage our employees. Our failure to effectively manage growth could have a material adverse effect on our results of operations.

If our manufacturing processes and services do not comply with applicable statutory and regulatory requirements, or if we manufacture products containing design or manufacturing defects, demand for our services may decline and we may be subject to liability claims.

We manufacture and design products to our customers’ specifications, and, in some cases, our manufacturing processes and facilities may need to comply with applicable statutory and regulatory requirements. For example, medical devices that we manufacture or design, as well as the facilities and manufacturing processes that we use to produce them, are regulated by the Food and Drug Administration and non-U.S. counterparts of this agency. In addition, our customers’ products and the manufacturing processes that we use to produce them often are highly complex. As a result, products that we manufacture may at times contain manufacturing or design defects, and our manufacturing processes may be subject to errors or not be in compliance with applicable statutory and regulatory requirements. Defects in the products we manufacture or design, whether caused by a design, manufacturing or component failure or error, or deficiencies in our manufacturing processes, may result in delayed shipments to customers or reduced or canceled customer orders. If these defects or deficiencies are significant, our business reputation may also be damaged. The failure of the products that we manufacture or our manufacturing processes and facilities to comply with applicable statutory and regulatory requirements may subject us to legal fines or penalties and, in some cases, require us to shut down or incur considerable expense to correct a manufacturing process or facility. Our customers are required to indemnify us against liability associated with designing products to meet their specifications. However, if our customers are responsible for the defects, they may not, or may not have resources to, assume responsibility for any costs or liabilities arising from these defects, which could expose us to additional liability claims.

Energy price increases may negatively impact our results of operations.

Certain components that we use in our manufacturing process are petroleum-based. In addition, we, along with our suppliers and customers, rely on various energy sources in our transportation activities. While significant uncertainty currently exists about the future levels of energy prices, a significant increase is possible. Increased energy prices could cause an increase to our raw material costs and transportation costs. In addition, increased transportation costs related to certain suppliers and customers could be passed along to us. We may not be able to increase our product prices enough to offset these increased costs. In addition, any increase in our product prices may reduce our future customer orders and profitability.

Disruptions to our information systems, including security breaches, losses of data or outages, could adversely affect our operations.

We rely on information technology networks and systems to process, transmit and store electronic information. In particular, we depend on our information technology infrastructure for a variety of functions, including worldwide financial reporting, inventory management, procurement, invoicing and email communications. Any of these systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, terrorist attacks and similar events. Despite the implementation of network security measures, our systems and those of third parties on which we rely may also be vulnerable to computer viruses, break-ins and similar disruptions. If we or our vendors are unable to prevent such outages and breaches, our operations could be disrupted.

We are involved in various legal proceedings.

In the past, we have been notified of claims relating to various matters including contractual matters, intellectual property rights or other issues arising in the ordinary course of business. In the event of such a claim, we may be required to spend a significant amount of money to defend or otherwise address the claim. Any litigation or dispute resolution, even where a claim is without merit, could result in substantial costs and diversion of resources. Accordingly, the resolution or adjudication of such disputes, even those encountered in the ordinary course of business, could have a material effect on our business, consolidated financial conditions and results of operations.

Our levels of insurance coverage may not be sufficient for potential damages, claims or losses.

We have various forms of business and liability insurance which we believe are appropriate based on the needs of companies in our industry. As a result, not all of our potential business risks or potential losses would be covered by our insurance policies. If we sustain a significant claim or loss which is not covered by insurance, our net income could be negatively impacted.

Changes in securities laws and regulations will increase our costs and risk of noncompliance.

We ~~are required to file as an accelerated filer. As such, we~~ are subject to additional requirements contained in the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act) and more recently the Dodd-Frank Act. The Sarbanes-Oxley and Dodd-Frank Acts required or will require changes in some of our corporate governance, securities disclosure and compliance practices. In response to the requirements of the Sarbanes-Oxley and Dodd-Frank Acts, the SEC and NASDAQ promulgated new rules and additional rulemaking is expected in the future. Compliance with these new rules and future rules has increased and may increase further our legal, financial and accounting costs as well as a potential risk of noncompliance. Absent significant changes in related rules, which we cannot assure, we anticipate some level of increased costs related to these new regulations to continue indefinitely. We also expect these developments to make it more difficult and more expensive to obtain director and officer liability insurance, and we may be forced to accept reduced coverage or incur substantially higher costs to obtain coverage. Likewise, these developments may make it more difficult for us to attract and retain qualified members of our Board of Directors or qualified management personnel. Further, the costs associated with the compliance with and implementation of procedures under these and future laws and related rules could have a material impact on our results of operations. In addition, the costs associated with noncompliance with additional securities laws and regulations could also impact our business.

We may encounter complications with acquisitions, which could potentially harm our business.

Any current or future acquisitions may require additional equity financing, which could be dilutive to our existing shareholders, or additional debt financing, which could potentially affect our credit ratings. Any downgrades in our credit ratings associated with an acquisition could adversely affect our ability to borrow by resulting in more restrictive borrowing terms. To integrate acquired businesses, we must implement our management information systems, operating systems and internal controls, and assimilate and manage the personnel of the acquired operations. The integration of acquired businesses may be further complicated by difficulties managing operations in geographically dispersed locations. The integration of acquired businesses may not be successful and could result in disruption by diverting management’s attention from the core business. In addition, the integration of acquired businesses may require that we incur significant restructuring charges or other increases in our expenses and working capital requirements, which reduce our return on invested capital.

Acquisitions may involve numerous other risks and challenges including but not limited to: potential loss of key employees and customers of the acquired companies; the potential for deficiencies in internal controls at acquired companies; lack of experience operating in the geographic market or industry sector of the acquired business; constraints on available liquidity, and exposure to unanticipated liabilities of acquired companies. These and other factors could harm our ability to achieve anticipated levels of profitability at acquired operations or realize other anticipated benefits of an acquisition, and could adversely affect our consolidated business and operating results.

Changes in financial accounting standards may affect our reported financial condition or results of operations as well increase costs related to implementation of new standards and modifications to internal controls.

Our consolidated financial statements are prepared in conformity with accounting standards generally accepted in the United States, or U.S. GAAP. These principles are subject to amendments made primarily by the Financial Accounting Standards Board (FASB) and the Securities and Exchange Commission (SEC). A change in those policies can have a significant effect on our reported results and may affect our reporting of transactions which are completed before a change is announced. Changes to accounting rules or challenges to our interpretation or application of the rules by regulators may have a material adverse effect on our reported financial results or on the way we conduct business. In addition, the continued convergence of U.S. GAAP and International Financial Reporting Standards (“IFRS”) creates uncertainty as to the financial accounting policies and practices we will need to adopt in the future.


~~Item 3.~~	~~Quantitative and Qualitative Disclosures About Market Risk~~

Item 3.Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

We are subject to the risk of fluctuating interest rates in the normal course of business. Our major market risk relates to our secured debt. Our asset-based senior revolving credit facility ~~term loan~~ and equipment ~~term loan~~financing facility are secured by substantially all of our assets. The interest rates applicable to our asset-based senior revolving credit facility ~~term loan and equipment term loan~~ fluctuate with ~~the Wells Fargo Bank, N.A. prime rate and~~ LIBOR rates. There was outstanding ~~$32.0~~$80.7 million in borrowings under our asset-based senior revolving credit facility ~~$13.3 million outstanding on our term loan~~ and ~~$1.3~~$4.9 million outstanding on our equipment ~~term loan~~financing facility as of ~~December 28, 2019.~~September 26, 2020. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Capital Resources and Liquidity” and Note 4 – “Long-Term Debt” to the Consolidated Financial Statements for additional information regarding our revolving credit facility and term loans.

Foreign Currency Exchange Risk

A significant portion of our operations are in foreign locations. As a result, transactions occur in currencies other than the U.S. dollar. Exchange rate fluctuations among other currencies used by us would directly or indirectly affect our financial results. We currently use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. There was outstanding ~~$25.8~~$30.0 million of foreign currency forward contracts as of ~~December 28, 2019.~~September 26, 2020. The fair value of these contracts was ~~$3.1~~$0.9 million. See Note 10 – “Derivative Financial Instruments” to the Consolidated Financial Statements for additional information regarding our derivative instruments.


~~Item 4.~~	~~Controls and Procedures~~

Item 4.Controls and Procedures

It is the responsibility of our management to establish, maintain, and monitor disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 are recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms. Additionally, these disclosure controls include controls and procedures that are designed to accumulate and communicate the information required to be disclosed to our company’s Chief Executive Officer and Chief Financial Officer, allowing for timely decisions regarding required disclosures. As of the end of the period covered by this report, our management carried out an evaluation, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(f). Based on our assessment, we believe that as of ~~December 28, 2019~~,September 26, 2020, the Company’s disclosure controls and procedures are effective based on that criteria.

Due to inherent limitations of any internal control system, management acknowledges that there are limitations as to the effectiveness of internal controls over financial reporting and therefore recognize that only reasonable assurance can be gained from any internal control system. Accordingly, our internal control system may not detect or prevent material misstatements in our financial statements and projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

There have been no significant changes in our internal controls over financial reporting during the three months ended ~~December 28, 2019~~September 26, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)).

PART II. OTHER INFORMATION:


~~Item 1.~~	~~Legal Proceedings~~

Item 1.Legal Proceedings

We are involved in various legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.


~~Item 1A.~~	~~Risk Factors~~

Item 1A.Risk Factors

Information regarding risk factors appear in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Item 3, “Quantitative and Qualitative Disclosures about Market Risk” of this Form 10-Q.

There are no material changes to the risk factors set forth in Part I Item 1A in the Company’s Annual Report on Form 10-K for the year ended June ~~29, 2019~~.27, 2020.

Item 6.

Exhibits

~~Item 6.~~

~~Exhibits~~31.1

~~31.1~~

Certification of Chief Executive Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)

31.2

Certification of Chief Financial Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)

32.1

Certification of Chief Executive Officer (18 U.S.C. 1350)

32.2

Certification of Chief Financial Officer (18 U.S.C. 1350)

101.INS

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

XBRL Taxonomy Extension Schema Document *

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document *

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document *

101.LAB

XBRL Taxonomy Extension Label Linkbase Document *

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document *

104

Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extention information contained in Exhibits 101.INS, 101.SCH, 101.CAL, 101.DEF, 101.LAB and 101.PRE)

* Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities and Exchange Act of 1934, as amended and otherwise are not subject to liability under those sections.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.



KEY TRONIC CORPORATION

/s/ CRAIG D. GATES
Craig D. Gates	Date:	~~February~~November 5, 2020
President and Chief Executive Officer
(Principal Executive Officer)

/s/ Brett R. Larsen
Brett R. Larsen	Date:	~~February~~November 5, 2020
Executive Vice President of Administration, Chief Financial Officer and Treasurer
(Principal Financial Officer)

3631



	July 26, 2019		July 27, 2018
SARs Granted	170,000		161,250
Strike Price	$	4.93	$	8.17
Fair Value	$	1.23	$	2.27



	December 28, 2019
	Amortization Period in Years	Gross Carrying Amount		Accumulated Amortization			Impairment Recognized		Derecognition Favorable Lease per ASC 842			Net Carrying Amount
Intangible assets:
Favorable Lease Agreements	4 - 7	2,941		(2,284		)	—		(657		)	—
Total		$	2,941	$	(2,284	)	$	—	$	(657	)	$	—



	Contract Assets
Beginning balance, June 29, 2019	$	22,161
Revenue recognized	219,144
Amounts collected or invoiced	(224,234		)
Ending balance, September 28, 2019	$	17,071



Lease cost	Classification	Three-Month Period Ended		Six-Month Period Ended
Operating lease cost	Cost of sales	$	1,161	$	2,319
Operating lease cost	Selling, general and administrative expenses	331		598
Total lease cost		$	1,492	$	2,917



Fiscal Years Ending	Operating Leases
2020	$	4,777
2021	3,563
2022	2,641
2023	1,866
2024	1,271
Thereafter	4,121
Total minimum lease payments	$	18,239